<SEC-DOCUMENT>0000921895-25-001282.txt : 20250506
<SEC-HEADER>0000921895-25-001282.hdr.sgml : 20250506
<ACCEPTANCE-DATETIME>20250506090916
ACCESSION NUMBER:		0000921895-25-001282
CONFORMED SUBMISSION TYPE:	PREC14A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20250505
DATE AS OF CHANGE:		20250506

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brookdale Senior Living Inc.
		CENTRAL INDEX KEY:			0001332349
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-NURSING & PERSONAL CARE FACILITIES [8050]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				203068069
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PREC14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32641
		FILM NUMBER:		25915594

	BUSINESS ADDRESS:	
		STREET 1:		105 WESTWOOD PLACE
		STREET 2:		SUITE 400
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		(615) 221-2250

	MAIL ADDRESS:	
		STREET 1:		105 WESTWOOD PLACE
		STREET 2:		SUITE 400
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ortelius Advisors, L.P.
		CENTRAL INDEX KEY:			0001804502
		ORGANIZATION NAME:           	
		EIN:				300870509
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PREC14A

	BUSINESS ADDRESS:	
		STREET 1:		450 PARK AVENUE, SUITE 2700
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		917-595-5010

	MAIL ADDRESS:	
		STREET 1:		450 PARK AVENUE, SUITE 2700
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>PREC14A
<SEQUENCE>1
<FILENAME>prec14a11126009_05052025.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Rule
14a-101)</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">INFORMATION REQUIRED IN PROXY STATEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">SCHEDULE 14A INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Amendment No. )</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Filed by the Registrant &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Filed by a Party other than the Registrant &#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9746;</TD><TD>Preliminary Proxy Statement</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Definitive Proxy Statement</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Definitive Additional Materials</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Soliciting Material Under &sect; 240.14a-12</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; text-align: center; vertical-align: top; border-bottom: Black 0.5pt solid">BROOKDALE SENIOR LIVING INC.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center; vertical-align: top"><P>(Name of Registrant as Specified In Its Charter)</P>

</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center; vertical-align: top; border-bottom: Black 0.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ORTELIUS ADVISORS, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">PANGAEA VENTURES, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">ORTELIUS ADVISORS GP I, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">PETER DESORCY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">STEVEN J. INSOFT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">PAULA J. POSKON</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">FRANK J. SMALL</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">IVONA SMITH</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">STEVEN L. VICK</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">LORI B. WITTMAN</P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center; vertical-align: top"><P>(Name of Persons(s) Filing Proxy Statement, if other than the Registrant)</P>

</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Payment of Filing Fee (Check all boxes that apply):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9746;</TD><TD>No fee required</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Fee paid previously with preliminary materials</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</TD></TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; color: red"><B>PRELIMINARY COPY SUBJECT TO COMPLETION<BR>
DATED MAY 5, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ORTELIUS ADVISORS, L.P.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0in">_______________, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">Dear Fellow Brookdale Senior Living Stockholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">Ortelius
Advisors, L.P., together with its affiliates, beneficially owns 2,504,155 shares of Common Stock, $0.01 par value per share, of Brookdale
Senior Living Inc., a Delaware corporation (&ldquo;Brookdale&rdquo; or the &ldquo;Company&rdquo;), constituting approximately 1.3% of
the shares outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">We
believe Brookdale has significant upside potential and multiple paths to building and unlocking sustainable long-term value for stockholders,
but that value has been trapped under the stewardship of a Board of Directors that has failed to hold management accountable despite years
of underperformance and chronic undervaluation. Although the Board belatedly transitioned away from the Company&rsquo;s former CEO, whom
the Board supported and defended for years, it only did so after we launched our public campaign, and the Board was confronted with demands
for change from stockholders. We believe that meaningful stockholder-driven change to the composition of the Board, and the addition of
skilled and experienced new directors with fresh perspectives and no ties to the legacy leadership, is necessary to drive real and enduring
change in the best interest of stockholders. That is why we are seeking your support to elect our six highly qualified director candidates
at the Company&rsquo;s 2025 annual meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We urge you to carefully
consider the information contained in the attached Proxy Statement and support our efforts by signing, dating and returning the enclosed
<B>WHITE</B> universal proxy card today. The attached Proxy Statement and the enclosed <B>WHITE</B> universal proxy card are first being
furnished to stockholders on or about _____________, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If you have already voted
for the incumbent management slate on the Company&rsquo;s universal proxy card, you have every right to change your vote by signing, dating,
marking your vote and returning a later dated <B>WHITE </B>universal proxy card or by voting in person at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If you have any questions
or require any assistance with your vote, please contact Saratoga Proxy Consulting LLC, which is assisting us, at its address and toll-free
number listed on the following page.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.5in">Thank you for your support,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.5in">/s/ Peter DeSorcy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">Peter DeSorcy<BR>
Ortelius Advisors, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; border: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>If you have any questions, require assistance in
    voting your </I><B>WHITE</B> <I>universal proxy card,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>or need additional copies of Ortelius&rsquo; proxy
    materials,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>please contact:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="Saratoga Proxy Consulting, LLC" STYLE="height: 54px; width: 206px"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">520 8<SUP>th</SUP> Avenue, 14<SUP>th</SUP> Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">New York, NY 10018</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(212) 257-1311</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(888) 368-0379</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">info@saratogaproxy.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: red"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: red"><B>PRELIMINARY COPY SUBJECT TO COMPLETION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; color: red"><B>DATED MAY 5, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ANNUAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>BROOKDALE SENIOR LIVING INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>_________________________<BR>
<BR>
PROXY STATEMENT<BR>
OF<BR>
ORTELIUS ADVISORS, L.P.<BR>
_________________________<BR>
<BR>
PLEASE SIGN, DATE AND MAIL THE ENCLOSED <U>WHITE</U> UNIVERSAL PROXY CARD TODAY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">Ortelius
Advisors, L.P., together with its affiliates (&ldquo;Ortelius&rdquo; or &ldquo;we&rdquo;), beneficially owns 2,504,155 shares of Common
Stock, $0.01 par value per share (the &ldquo;Common Stock&rdquo;), of Brookdale Senior Living Inc., a Delaware corporation (&ldquo;Brookdale&rdquo;
or the &ldquo;Company&rdquo;), constituting approximately 1.3% of the shares outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">After
years of underperformance and chronic undervaluation at Brookdale, we believe that meaningful stockholder-driven change to the composition
of the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;), and the addition of skilled and experienced new directors with fresh
perspectives and no ties to the legacy leadership, is necessary to drive real and enduring change in the best interest of stockholders.
Accordingly, we are seeking your support for the election of our six highly qualified nominees as directors at the Company&rsquo;s 2025
annual meeting of stockholders to be held on _________, 2025 at ______ Central Time at ___________ (including any adjournments, postponements
or continuations thereof and any meeting which may be called in lieu thereof, the &ldquo;Annual Meeting&rdquo;), for the following items
of business:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">To elect Ortelius&rsquo; six (6) director nominees, Steven J. Insoft, Paula J. Poskon, Frank J. Small,
Ivona Smith, Steven L. Vick, and Lori B. Wittman (collectively, the &ldquo;Ortelius Nominees&rdquo;), for a one-year term each ending
at the 2026 annual meeting of stockholders (the &ldquo;2026 Annual Meeting&rdquo;) and until his or her successor has been duly elected
and qualified, or until such director&rsquo;s death, resignation or removal;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">To vote on the Company&rsquo;s proposal to approve, on an advisory basis, the Company&rsquo;s named executive
officer compensation;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">To vote on the Company&rsquo;s proposal to ratify the appointment of Ernst &amp; Young LLP as the Company&rsquo;s
independent registered public accounting firm for 2025; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">To transact such other business as may properly come before the Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">This Proxy Statement and the enclosed <B>WHITE</B>
universal proxy card are first being mailed to stockholders on or about _______________, 2025.</P>

<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Board is currently
composed of nine directors, each with terms expiring at the Annual Meeting. Current director Mr. Bumstead is not standing for re-election
at the Annual Meeting, and the Company has disclosed in its proxy statement that the number of directors of the Company will be fixed
at eight as of the Annual Meeting, although the Company indicated that it plans to increase the size of the Board to nine directors and
add the Company&rsquo;s new CEO once identified. Through the attached Proxy Statement and enclosed <B>WHITE</B> universal proxy card,
we are soliciting proxies to elect not only the six Ortelius Nominees, but also two of the Company&rsquo;s nominees whose election we
do not oppose, _______ and _______ (the &ldquo;Unopposed Company Nominees&rdquo;). Ortelius and Brookdale will each be using a universal
proxy card for voting on the election of directors at the Annual Meeting, which will include the names of all nominees for election to
the Board. Stockholders will have the ability to vote for up to eight nominees on Ortelius&rsquo; enclosed <B>WHITE</B> universal proxy
card. Any stockholder who wishes to vote for any of the Company&rsquo;s nominees in addition to the Ortelius Nominees may do so on Ortelius&rsquo;
<B>WHITE</B> universal proxy card. While, there is no need to use the Company&rsquo;s blue universal proxy card or voting instruction
form, regardless of how you wish to vote, you may still vote &ldquo;FOR&rdquo; the Ortelius Nominees on the Company&rsquo;s blue proxy
card or blue voting instruction form. Only your latest dated vote will count.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Your vote to elect the
six Ortelius Nominees will have the legal effect of replacing six incumbent directors. If at least five Ortelius Nominees are elected,
they will represent a majority of the members of the Board. If elected, the Ortelius Nominees, subject to their fiduciary duties as directors,
will seek to work with the other members of the Board to assess all paths to enhancing stockholder value. There can be no assurance that
any of the Company&rsquo;s nominees will serve as directors if all or some of the Ortelius Nominees are elected. The names, backgrounds
and qualifications of the Company&rsquo;s nominees, and other information about them, can be found in the Company&rsquo;s proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Stockholders are permitted
to vote for less than eight nominees or for any combination (up to eight total) of the Ortelius Nominees and the Company&rsquo;s nominees
on the <B>WHITE</B> universal proxy card. However, if stockholders choose to vote for any of the Company&rsquo;s nominees, we recommend
that stockholders vote in favor of the Unopposed Company Nominees to help achieve a Board composition that we believe is in the best interest
of all stockholders. Ortelius urges stockholders using our <B>WHITE</B> universal proxy card to vote <B>&ldquo;FOR&rdquo;</B> all of the
Ortelius Nominees and <B>&ldquo;FOR&rdquo;</B> the Unopposed Company Nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>IF YOU MARK FEWER THAN
EIGHT &ldquo;FOR&rdquo; BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, OUR WHITE UNIVERSAL PROXY CARD, WHEN DULY EXECUTED, WILL BE VOTED
ONLY AS DIRECTED. IF NO DIRECTION IS INDICATED WITH RESPECT TO HOW YOU WISH TO VOTE YOUR SHARES, THE PROXIES NAMED THEREIN WILL VOTE SUCH
SHARES &ldquo;FOR&rdquo; THE SIX ORTELIUS NOMINEES AND THE TWO UNOPPOSED COMPANY NOMINEES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>IMPORTANTLY, IF YOU
MARK MORE THAN EIGHT &ldquo;FOR&rdquo; BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, ALL OF YOUR VOTES &ldquo;FOR&rdquo; THE ELECTION
OF DIRECTORS WILL BE DEEMED INVALID.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company has set the
close of business on ________, 2025 as the record date for determining stockholders entitled to notice of and to vote at the Annual Meeting
(the &ldquo;Record Date&rdquo;). Each share of Common Stock is entitled to one vote for each of the proposals to be voted on. The address
of the principal executive offices of the Company is 105 Westwood Place, Suite 400, Brentwood, Tennessee 37027. Stockholders of record
at the close of business on the Record Date will be entitled to vote at the Annual Meeting. According to the Company, as of the Record
Date, there were _______ shares of Common Stock outstanding and entitled to vote at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As of the date hereof,
Ortelius Advisors, L.P., a Delaware limited partnership (&ldquo;OA&rdquo;), and the other Participants (as defined in below) collectively
beneficially own 2,504,155 shares of Common Stock (the &ldquo;Ortelius Shares&rdquo;). We intend to vote the Ortelius Shares <B>&ldquo;FOR&rdquo;
</B>the election of the Ortelius Nominees and the Unopposed Company Nominees, <B>&ldquo;AGAINST&rdquo;</B> the approval of the advisory
vote on the Company&rsquo;s named executive officer compensation, and <B>&ldquo;FOR&rdquo;</B> the ratification of the appointment of
Ernst &amp; Young LLP as the Company&rsquo;s independent registered public accounting firm for 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We urge you to carefully
consider the information contained in this Proxy Statement and then support our efforts by signing, dating and returning the enclosed
<B>WHITE</B> universal proxy card today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">THIS SOLICITATION IS BEING
MADE BY ORTELIUS AND NOT ON BEHALF OF THE BOARD OR MANAGEMENT OF THE COMPANY. WE ARE NOT AWARE OF ANY OTHER MATTERS TO BE BROUGHT BEFORE
THE ANNUAL MEETING OTHER THAN AS SET FORTH IN THIS PROXY STATEMENT. SHOULD OTHER MATTERS, WHICH ORTELIUS IS NOT AWARE OF A REASONABLE
TIME BEFORE THIS SOLICITATION, BE BROUGHT BEFORE THE ANNUAL MEETING, THE PERSONS NAMED AS PROXIES IN THE ENCLOSED <B>WHITE </B>UNIVERSAL
PROXY CARD WILL VOTE ON SUCH MATTERS IN THEIR DISCRETION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">ORTELIUS URGES YOU TO SIGN,
DATE AND RETURN THE <B>WHITE </B>UNIVERSAL PROXY CARD IN FAVOR OF THE ELECTION OF THE ORTELIUS NOMINEES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">IF YOU HAVE ALREADY SENT
A PROXY CARD FURNISHED BY COMPANY MANAGEMENT OR THE BOARD, YOU MAY REVOKE THAT PROXY AND VOTE ON EACH OF THE PROPOSALS DESCRIBED IN THIS
PROXY STATEMENT BY SIGNING, DATING AND RETURNING THE ENCLOSED <B>WHITE</B> UNIVERSAL PROXY CARD. THE LATEST DATED PROXY IS THE ONLY ONE
THAT COUNTS. ANY PROXY MAY BE REVOKED AT ANY TIME PRIOR TO THE ANNUAL MEETING BY DELIVERING A WRITTEN NOTICE OF REVOCATION OR A LATER
DATED PROXY FOR THE ANNUAL MEETING OR BY VOTING IN PERSON AT THE ANNUAL MEETING.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Important Notice Regarding the Availability of
Proxy Materials for the Annual Meeting &ndash;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">This Proxy Statement and our WHITE universal proxy
card are available at:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">www.__________.com</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">IMPORTANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in"><B>Your vote is important,
no matter how many or how few shares of Common Stock you own. Ortelius urges you to sign, date, and return the enclosed WHITE universal
proxy card today to vote &ldquo;FOR&rdquo; the election of the Ortelius Nominees and in accordance with Ortelius&rsquo; recommendations
on the other proposals on the agenda for the Annual Meeting.</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">If your shares of Common Stock are registered in your own name, please sign and date the enclosed <B>WHITE
</B>universal proxy card and return it to Ortelius, c/o Saratoga Proxy Consulting, LLC (&#8220;Saratoga&#8221;), in the enclosed postage-paid
envelope today.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">If your shares of Common Stock are held in a brokerage account or bank, you are considered the beneficial
owner of the shares of Common Stock, and these proxy materials, together with a <B>WHITE</B> voting instruction form, are being forwarded
to you by your broker or bank. As a beneficial owner, if you wish to vote, you must instruct your broker, trustee or other representative
how to vote. Your broker cannot vote your shares of Common Stock on your behalf without your instructions.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Depending upon your broker or custodian, you should be able to vote either by toll-free telephone or by
the Internet. Please refer to the enclosed <B>WHITE</B> voting instruction form for instructions on how to vote electronically. You may
also vote by signing, dating and returning the enclosed <B>WHITE</B> voting instruction form in the enclosed pre-paid return envelope.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">You may vote your shares at the Annual Meeting. Even if you plan to attend the Annual Meeting, we recommend
that you submit your <B>WHITE </B>universal proxy card by mail by the applicable deadline so that your vote will be counted if you later
decide not to attend the Annual Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As Ortelius is using a
 &ldquo;universal&rdquo; proxy card containing all six of the Ortelius Nominees as well as the Company&rsquo;s nominees, there is no need
to use any other proxy card regardless of how you intend to vote. <B>Ortelius strongly urges you NOT to sign or return any blue proxy
cards or voting instruction forms that you may receive from the Company. </B>Even if you return the blue management proxy card marked
 &ldquo;withhold&rdquo; as a protest against the incumbent directors, it will revoke any proxy card you may have previously sent to us.<BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; border: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>If you have any questions, require assistance in
    voting your </I><B>WHITE</B> <I>universal proxy card,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>or need additional copies of Ortelius&rsquo; proxy
    materials,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>please contact:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_002.jpg" ALT="Saratoga Proxy Consulting, LLC" STYLE="height: 54px; width: 206px"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">520 8<SUP>th</SUP> Avenue, 14<SUP>th</SUP> Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">New York, NY 10018</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(212) 257-1311</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(888) 368-0379</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">info@saratogaproxy.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>BACKGROUND TO THE SOLICITATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The following is a chronology of events leading up to this proxy
solicitation:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; line-height: 107%">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="line-height: 107%">On March 5, 2025, </FONT>Ortelius delivered a notice of nomination (the
 &#8220;Nomination Notice&#8221;) to the Company nominating Steven J. Insoft, Paula J. Poskon, Frank J. Small, Ivona Smith, Steven L. Vick,
and Lori B. Wittman (referred to as the Ortelius Nominees) as candidates for election to the Board at the Annual Meeting. Ortelius also
issued a press release announcing that it delivered the Nomination Notice, outlining its case for meaningful change at Brookdale following
years of underperformance. Later that day, the Company issued a press release acknowledging Ortelius&#8217; delivery of the Nomination
Notice.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On March 7, 2025, Jessica Hazel, the Company&#8217;s Head of Investor Relations, emailed Mr. DeSorcy to
set up a call with Ms. Baier and Dawn Kussow, the Company&#8217;s Chief Financial Officer, and Ms. Hazel. Later that day, Mr. DeSorcy
responded with availability the week of March 17, and requested that independent directors be included on that call. Ms. Hazel informed
Mr. DeSorcy that Denise W. Warren, Non-Executive Chairman of the Board, and Lee Wielansky, a member of the Board, also would join the
call.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On March 20, 2025, Mr. DeSorcy had a call with Mses. Baier, Kussow, Hazel and Warren, and Mr. Wielansky.
On the call, Mr. DeSorcy shared his views regarding the Company&#8217;s underperformance and the need for meaningful change on the Board
 &#8211; more than just one or two director seats &#8211; to unlock the Company&#8217;s value. Ms. Baier defended the Company&#8217;s record
and strategy. Later that day, counsel to Ortelius and the Company spoke, and the Company&#8217;s counsel requested that the Ortelius Nominees
be made available for interviews with the Company. The Company&#8217;s counsel indicated that the interviews would be part of the Board&#8217;s
ordinary course evaluation of potential candidates, and the Company was not offering to put any of the Ortelius Nominees on the Board
as part of a potential resolution of the election contest. Ortelius&#8217; counsel noted that Ortelius would make the Ortelius Nominees
available for interviews if Ortelius and the Company are in alignment on a potential resolution of the election contest, and based on
the call that did not appear to be the case.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On March 22, 2025, the Company&#8217;s Executive Vice President, General Counsel and Secretary, Chad White,
delivered letters directly to each of the Ortelius Nominees. In the letters, on behalf of the Nominating and Corporate Governance Committee
of the Board, Mr. White requested that the Ortelius Nominees schedule interviews &#8220;as part of the Board&#8217;s normal director nominee
evaluation process.&#8221; Mr. White further requested that the Ortelius Nominees complete an enclosed director and officer questionnaire
in advance of the interview. Ms. Baier also sent separate notes to Ortelius Nominees offering to speak with them. The Ortelius Nominees
did not agree to submit the questionnaires or participate in the interviews.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On April 1, 2025, Ortelius delivered to the Company a books and records demand for stockholder list materials
(the &#8220;Stockholder List Demand&#8221;).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On April 14, 2025, Ortelius and the Company entered into a confidentiality agreement with respect to the
Stockholder List Demand.</TD></TR></TABLE>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On April 14, 2025, the Company announced that by mutual agreement between Ms. Baier and the Board, Ms.
Baier ceased serving as President, CEO, and director of the Company, effective April 13, 2025, and entered into a separation agreement
providing Ms. Baier with certain severance payments and benefits. The Company did not file a copy of the separation agreement with the
SEC. The Company announced that the Board appointed Ms. Warren, current Chairman of the Board, to serve as Interim CEO, and the Board
initiated a search for the Company&#8217;s next CEO. The Company also announced its appointment of Mark Fioravanti to the Board, and that
Frank M. Bumstead, a current member of the Board, informed the Board that he would not stand for re-election at the Annual Meeting. According
to the Company&#8217;s proxy statement, Mr. Fioravanti was identified as a potential candidate for consideration by Ms. Baier.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On April 24, 2025, Ortelius sent a public letter to Brookdale stockholders outlining pathways to build
and unlock sustainable long-term value, and issued a press release including a copy of the letter. In the letter, Ortelius stated that
the Board&#8217;s belated actions to change the Company&#8217;s leadership, following years of defending the Company&#8217;s CEO and Ortelius&#8217;
launch of a director election contest, are &#8220;too little, too late&#8221;, and that Ortelius remains committed to holding the Board
accountable, providing viable paths to reversing the Company&#8217;s decline, and maximizing long-term stockholder value.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Also on April 24, 2025, the Company announced its appointment of Joshua Hausman to the Board. According
to the Company&#8217;s proxy statement, Mr. Hausman was identified as a potential candidate for consideration by Ms. Warren.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On April 26, 2025, through its counsel, Ortelius requested a call with the Company to discuss its public
letter and the possibility of resolving the election contest.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On April 27, 2025, Mr. DeSorcy had a call with Ms. Warren and Mr. Wielansky. On the call, Mr. DeSorcy
discussed his views regarding the Company expressed in his public letter, including the Company&#8217;s significant upside potential.
He noted that Ortelius views its investment in the Company as long-term, and that the Company should not be looking to sell assets on
the cheap. He expressed interest in discussing terms of a potential settlement of the election contest involving adding certain of the
Ortelius Nominees to the Board, and noted that he was prepared to make the Ortelius Nominees available immediately for interviews. Ms.
Warren said she would need to confer with the Board on whether she would be able to discuss a potential resolution to the election contest
with Ortelius.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On April 29, 2025, Mr. DeSorcy had a follow-up call with Ms. Warren and Mr. Wielansky. On the call, Ms.
Warren and Mr. Wielansky informed Mr. DeSorcy that the Board was not willing to appoint any of the Ortelius Nominees to the Board.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="line-height: 107%">Also on April 29, 2025, the Company delivered a letter to Ortelius</FONT>
pursuant to Rule 14a-19(d) <FONT STYLE="line-height: 107%">under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;) </FONT>of its intention to nominate and solicit proxies for each of Denise W. Warren, Jordan R. Asher, Claudia N. Drayton,
Mark Fioravanti, Victoria L. Freed, Joshua Hausman, Elizabeth B. Mace and Lee S. Wielansky for election to the Board at the Annual Meeting.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On April 30, 2025, the Company filed its preliminary proxy statement with the SEC.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">On May 5, 2025, Ortelius filed this preliminary proxy statement with the SEC.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>REASONS FOR THE SOLICITATION</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Over the past seven years, and prior to the launch
of our public campaign to set the Company on a new course, investors in Brookdale have witnessed a massive destruction of stockholder
value. Based on our detailed research into the Company and its portfolio of high-quality assets, and experience with the senior housing
industry, we believe that the Company has significant upside potential and multiple paths to building and unlocking sustainable long-term
value for stockholders. However, that value has been trapped under the stewardship of the current Board.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">After we launched our public campaign, and the
Board heard demands for change from stockholders, the Board belatedly decided to transition away from the Company&rsquo;s former CEO Lucinda
(&ldquo;Cindy&rdquo;) Baier, whom the Board supported and defended for years, and rushed to appoint two new directors that were previously
known to Board members. But &ldquo;Better Late than Never&rdquo; cannot save this Board. After years of standing by and failing to hold
management accountable for the Company&rsquo;s abysmal performance and chronic undervaluation, this Board is not best suited to credibly
chart the path forward for the Company. We believe that meaningful stockholder-driven change to the composition of the Board, and the
addition of skilled and experienced new directors with fresh perspectives and no ties to the legacy leadership, is necessary to drive
real and enduring change in the best interest of stockholders.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Stockholders Have Suffered From Significant Stock
Price Underperformance</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&rsquo;s Total Stockholder Returns have
underperformed its peers and relevant indices over 1, 3, 5 and 7 year periods through the date prior to the announcement of our director
nominations. Over the past year, the Company has underperformed key industry peers Welltower Inc. by 66% and Ventas, Inc. by 62%.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>1</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 40%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Total Stockholder Returns</B></P></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>(2/21/24 - 3/4/25)</B></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>(2/21/22 - 3/4/25)</B></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>(2/21/20 - 3/4/25)</B></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>(2/21/18 - 3/4/25)</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Brookdale Senior Living Inc.</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">2 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(13 %)</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(30 %)</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">(37 %)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Welltower Inc.</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">68 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">103 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">106 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">266 % </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Ventas, Inc.</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">64 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">47 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">36 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">93 % </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">S&amp;P 500 Healthcare Index</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">4 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">22 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">56 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">100 % </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Russell 3000 Healthcare Index</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">3 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">19 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">46 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">88 % </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Bloomberg REIT Healthcare Index</TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">50 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">35 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">23 % </TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">104 % </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Source: Bloomberg. Returns are
adjusted for dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">Tellingly,
stockholders have reacted dramatically to the possibility of change at Brookdale driven by our public campaign. On the day we announced
our director nominations, Brookdale&rsquo;s stock rose 7% on heavy volume.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>2</SUP></FONT>
<FONT STYLE="background-color: white">On the day the Company announced </FONT>C<FONT STYLE="background-color: white">indy Baier&rsquo;s
departure, Brookdale&rsquo;s stock </FONT>jumped 9<FONT STYLE="background-color: white">%.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>3</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<HR ALIGN="LEFT" SIZE="1" STYLE="width: 5pc; margin-top: 12pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>1</SUP></FONT>
<FONT STYLE="font-size: 8">Bloomberg. Returns are adjusted for dividends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>2</SUP></FONT>
<FONT STYLE="font-size: 8">Bloomberg; March 5, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>3</SUP></FONT>
<FONT STYLE="font-size: 8">Bloomberg; April 14, 2025.</FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>A History of Operational and Strategic Issues</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">Under the leadership
of the Board, the Company has failed to </FONT>capitalize on its potential. T<FONT STYLE="background-color: white">he Company has sustained
a history of poor operational performance in almost all aspects of its business, including occupancy rates, NOI Margin, EBITDA Margin,
and free cash flow. Management has also made poor capital allocation decisions, which have prevented Brookdale from taking advantage of
significant growth opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; border: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><B>Occupancy Rate</B></TD>
    <TD STYLE="width: 75%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT></P>
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: -11pt 0 0 0.25in; text-align: justify; text-indent: 0">Dropped from
    85.2% to 79.4%<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>4</SUP></FONT>, versus 88.8% to 87.2% for
    the senior housing industry<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>5</SUP></FONT></P>
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT></P>
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: -11pt 0 0 0.25in; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Symbol"></FONT>147
    facilities, accounting for 23.7% of the owned and leased portfolios, reported occupancy rates of less than 70%<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>6</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="background-color: white"><B>NOI Margin</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT><FONT STYLE="background-color: white"></FONT></P>
                                                                                <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: -11pt 0 0 0.25in; text-align: justify; text-indent: 0"><FONT STYLE="background-color: white">Annual net operating income margin fell from 32.5% to 26.8%<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>7</SUP></FONT></FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="background-color: white"><B>EBITDA Margin</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT><FONT STYLE="background-color: white"></FONT></P>
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: -11pt 0 0 0.25in; text-align: justify; text-indent: 0"><FONT STYLE="background-color: white">The
    average annual adjusted EBITDA margin declined from 14.8% in 2011 - 2017, to 9.4% in 2018 - 2024<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>8</SUP></FONT></FONT></P>
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT></P>
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: -11pt 0 0 0.25in; text-align: justify; text-indent: 0">The
    leased portfolio <FONT STYLE="background-color: white">average annual </FONT>adjusted EBITDA margin was a meager 1.0% in <FONT STYLE="background-color: white">2018
    - 2024<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>9</SUP></FONT>, and </FONT>highly dilutive</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="background-color: white"><B>Free Cash Flow</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT><FONT STYLE="background-color: white"></FONT></P>
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: -11pt 0 0 0.25in; text-align: justify; text-indent: 0"><FONT STYLE="background-color: white">Cumulative
    free cash flow imploded</FONT> from $304 million in 2011 - 2017, to negative $660 million in 2018 - 2024<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>10</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="background-color: white"><B>Stockholder Value</B></FONT></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT></P>
    <P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: -11pt 0 0 0.25in; text-align: justify; text-indent: 0">Tangible
    book value per share plunged 83%, from $5.49 to $0.93<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>11</SUP></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">The responsibility
for all this ultimately falls on the Board.</FONT></P>

<HR ALIGN="LEFT" SIZE="1" STYLE="width: 5pc; margin-top: 12pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>4</SUP></FONT>
<FONT STYLE="font-size: 8">Brookdale Senior Living Inc., <I>Brookdale Senior Living Supplemental Information 4<SUP>th</SUP> Quarter 2017</I>.
Brookdale Senior Living Inc., <I>Brookdale Senior Living Supplemental Information 4<SUP>th</SUP> Quarter 2024</I>. Senior housing occupancy
per Brookdale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>5</SUP></FONT>
<FONT STYLE="font-size: 8">National Investment Center for Senior Housing and Care (NIC), <I>NIC MAP Vision</I>. Overall senior housing
combines majority IL and majority AL properties. Data for the Market Fundamentals is representative of the top 31 primary metropolitan
markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>6</SUP></FONT>
<FONT STYLE="font-size: 8">Brookdale Senior Living Inc., <I>Brookdale Senior Living Supplemental Information 4<SUP>th</SUP> Quarter 2024</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>7</SUP></FONT>
<FONT STYLE="font-size: 8">Brookdale Senior Living Inc., <I>Brookdale Senior Living Supplemental Information 4<SUP>th</SUP> Quarter 2017</I>.
Brookdale Senior Living Inc., <I>Brookdale Senior Living Supplemental Information 4<SUP>th</SUP> Quarter 2024</I>. Figures are segment
operating margin for all segments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>8</SUP></FONT>
<FONT STYLE="font-size: 8">Brookdale Senior Living Inc. 10-K filings, 2011 to 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>9</SUP></FONT>
<FONT STYLE="font-size: 8">Brookdale Senior Living Inc., <I>Brookdale Senior Living Supplemental Information, 2018 to 2024 quarterly
documents. </I> Revenue figures include other operating income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>10</SUP></FONT>
<FONT STYLE="font-size: 8">Free cash flow is defined as operating cash flow minus capital expenditures. Operating cash flow is net cash
provided by operating activities per 10-K filings. Cumulative free cash flow is the sum of annual free cash flows for the period noted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8"><SUP>11</SUP></FONT>
<FONT STYLE="font-size: 8">Tangible book value per share as of December 31, 2017 and December 31, 2024. Calculations use basic shares
outstanding as of February 20, 2018 and February 17, 2025. Tangible book value is defined as total assets minus goodwill minus total
liabilities. Tangible book value per share is defined as tangible book value divided by basic shares outstanding.</FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Reactionary and Defensive Response to Call for
Change</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: #FEFEFE">On March 5, 2025, we announced
our nomination of six highly qualified, independent director candidates for election to the Board at the Annual Meeting to effect meaningful
change, and hold the Board and management team accountable for Brookdale&rsquo;s dismal results. Since then, the Board heard loud and
clear how much stockholders want to see change at Brookdale. Cue the Board&rsquo;s long overdue transition away from the Company&rsquo;s
former CEO, and installation of long-time director Denise W. Warren, who served on the Board for most of the former CEO&rsquo;s tenure,
to lead the Company&rsquo;s transition and consider &ldquo;potential governance enhancements.&rdquo; Also cue a defensive refresh of the
Board, by rushing to appoint two new directors that were previously known to Board members over less than two weeks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: #FEFEFE">Stockholders have cheered
on change at the Company, but the Board supposes that amounts to an endorsement of the Board. We believe that to be wishful thinking.
The Board only took these actions after our launch of a director election contest, and the installation of Ms. Warren as interim CEO and
quick appointment of two new directors that were previously known to Board members, plainly shows a lack of appropriate succession planning
by the Board. Change at Brookdale will require durable change in its culture, and that starts at the top with the Board. We believe that
stockholders need to see that sort of meaningful change for the Company to rebuild its credibility with investors. Ortelius and its highly-qualified
candidates are <FONT STYLE="background-color: white">committed to accountability and turning the page on the Company&rsquo;s history of
value destruction to drive a better path forward.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: #FEFEFE"><FONT STYLE="background-color: white">We
attempted to work with the Board and reach a resolution that would both effect meaningful change to the Board and avoid a proxy contest
for the Company. The Board outright rejected the possibility of adding any of our highly-qualified candidates to the Board, after undergoing
its own quick defensive refresh. This reaction provided all of the confirmation we needed that this Board is more interested in its own
preservation than the best interests of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>A Path Forward</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We strongly believe that there are multiple ways to
win, and many paths to building and unlocking intrinsic value at Brookdale over the near- and long-term, including:</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#167;</FONT></TD><TD STYLE="text-align: justify">monetizing the underperforming owned properties</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#167;</FONT></TD><TD STYLE="text-align: justify">improving Brookdale&#8217;s financials</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#167;</FONT></TD><TD STYLE="text-align: justify">reducing mortgage debt</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#167;</FONT></TD><TD STYLE="text-align: justify">eliminating the leased portfolio</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#167;</FONT></TD><TD STYLE="text-align: justify">unlocking the value of the real estate</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#167;</FONT></TD><TD STYLE="text-align: justify">reviewing strategic alternatives</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#167;</FONT></TD><TD STYLE="text-align: justify">installing a new management team; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#167;</FONT></TD><TD STYLE="text-align: justify">refreshing the Board</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We intend to discuss these steps in greater detail
in our ongoing communications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>Our Director Nominees Have the Fresh Perspectives,
Skills and Experience Necessary to Drive Real and Enduring Change</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Our six highly qualified Ortelius Nominees
would bring to the Board the expertise, objectivity, and leadership required to instill discipline, refocus Brookdale&rsquo;s strategy,
and align decision-making with stockholder interests. With a refreshed Board in place, and selecting a new CEO that is committed to driving
value for stockholders, the Company can establish a path to sustainable, long-term value creation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Steven J. Insoft </B><I>has 35 years of experience as a senior executive,
including in senior housing, as well as financial expertise in the healthcare and real estate investment trust industries.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">35 years of experience, including Senior Housing, REIT&#8217;s, Operations, and Acquisitions/Divestitures</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Former Chief Corporate Development Officer at Omega Health Care Investors, Inc. (&#8220;Omega&#8221;)
(NYSE: OHI); former President and Chief Operating Officer at Aviv REIT (NYSE: AVIV) (bought by Omega); and former Senior Investment Officer
at Nationwide Health Properties, Inc. (NYSE: NHP) (later bought by Ventas, Inc.)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"><B>Paula Poskon</B><I> has 25 years
of experience, including in senior housing, and expertise in equity research and the real estate industry.</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">25 years of experience, including Senior Housing, REIT&#8217;s, Investment Banking, Capital Markets, and
Stockholder Communications</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Founder and President at STOV Advisory Services LLC, which offers professional consulting and advisory
services to company executives and institutional investors in the areas of real estate, capital markets, and investor relations; former
REIT Research Analyst at D.A. Davidson &amp; Co., Inc. and Robert W. Baird &amp; Co., Inc.; former Associate Equity Research Analyst and
Investment Banker at Lehman Brothers; current director at Cedar Realty Trust Inc. (NYSE: CDR.PRB and CDR.PRC); and former Director at
Wheeler REIT, Inc. (NYSE: WHLR)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"><B>Frank Small </B><I>has 25+ years of experience,
including in senior housing and real estate, and expertise in healthcare real estate assets.</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">25+ years of experience, including Senior Housing, Real Estate, Acquisitions/Divestitures, and Financial
Restructurings</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Former senior roles at Castle Lanterra; KKR &amp; Co.; Fortress Investment Group; JER Partners; and Cerberus
Real Estate Partners LLC</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"><B>Ivona Smith </B><I>has 30 years of experience,
including in operational and financial restructurings, and extensive expertise in the financial services industry, including internal
audit, risk management, restructuring advisory, valuation, and corporate finance.</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">30 years of experience, including Operational and Financial Restructurings</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Trustee of various litigation and liquidation trusts; former Managing Director at Fair Oaks Capital, LP;
co-founded and former Portfolio Manager at Restoration Capital Management LLC; former Co-Portfolio Manager at Tribeca Investments, LLC;
and current Director at Rayonier Advanced Materials Inc. (NYSE: RYAM)</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"><B>Steven Vick </B><I>has 35 years of experience
as a senior executive, including in the senior housing industry, and expertise in corporate turnarounds.</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">35 years of experience, including Senior Housing, Operations, and Turnarounds</TD></TR></TABLE>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Co-founded Pegasus Senior Living (partnered with Welltower Inc., managed and turned around 37 former Brookdale
communities); former Chief Executive Officer and Director at Assisted Living Concepts (led a post-bankruptcy turnaround, bought by Extendicare
Health Services); former President and Director at Alterra Healthcare Corporation (&#8220;Alterra&#8221;) (later merged with Brookdale);
and co-founded and former Director at Sterling House Corporation (brought public and merged with Alterra)</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: justify"><B>Lori Wittman </B><I>has 30+ years of extensive
experience in the real estate industry and deep expertise in financial management and corporate governance.</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">30+ years of experience, including Senior Housing, REIT&#8217;s, Operations, and Stockholder Communications</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">Former Chief Financial Officer at Care Capital Properties, Inc. (bought by Sabra Health Care REIT, Inc.);
former Senior Vice President of Capital Markets and Investor Relations at Ventas, Inc.; Senior Vice President and Treasurer at General
Growth Properties; current Chairman of the Board at NetSTREIT Corp. (NYSE: NTST); and current Lead Independent Director at Global Medical
REIT, Inc. (NYSE: GMRE)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">PROPOSAL 1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">ELECTION OF DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Board is currently
composed of nine directors, each with terms expiring at the Annual Meeting. Current director Mr. Bumstead is not standing for re-election
at the Annual Meeting, and the Company has disclosed in its proxy statement that the number of directors of the Company will be fixed
at eight as of the Annual Meeting, although the Company indicated that it plans to increase the size of the Board to nine directors and
add the Company&rsquo;s new CEO once identified. We are seeking your support at the Annual Meeting to elect our six Ortelius Nominees,
Steven J. Insoft, Paula J. Poskon, Frank J. Small, Ivona Smith, Steven L. Vick and Lori B. Wittman, for terms ending at the 2026 Annual
Meeting. Your vote to elect the six Ortelius Nominees will have the legal effect of replacing six incumbent directors. If at least five
Ortelius Nominees are elected, they will represent a majority of the members of the Board. If elected, the Ortelius Nominees, subject
to their fiduciary duties as directors, will seek to work with the other members of the Board to assess all paths to enhancing stockholder
value. There can be no assurance that any of the Company&rsquo;s nominees will serve as directors if all or some of the Ortelius Nominees
are elected. You should refer to the Company&rsquo;s proxy statement for the names, background, qualifications and other information concerning
the Company&rsquo;s nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Proxy Statement is
soliciting proxies to elect not only the six Ortelius Nominees, but also the two Unopposed Company Nominees. We have provided the required
notice to the Company pursuant to Rule 14a-19(b) under the Exchange Act, and we intend to solicit the holders of Common Stock representing
at least 67% of the voting power of Common Stock entitled to vote on the election of directors in support of director nominees other than
the Company&rsquo;s nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>THE ORTELIUS NOMINEES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Sets forth below are the
name, age, business address, and business experience for the past five years of the Ortelius Nominees, as well as a discussion of the
specific experience, qualifications, attributes and skills that led us to conclude that the Ortelius Nominees should serve as directors
of the Company. The nomination of the Ortelius Nominees was made in a timely manner and in compliance with the applicable provisions of
the Company&rsquo;s governing instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>Steven J. Insoft</B>, age 61,
has been an active real estate investor through private investment vehicles, with a focus on housing for the disabled, since January 2022.
Previously, Mr. Insoft served as Chief Corporate Development Officer of Omega Healthcare Investors, Inc. (NYSE: OHI) (&ldquo;Omega&rdquo;),
a real estate investment trust that provides real estate capital to the seniors housing and long-term healthcare industry, from April
2015 to January 2022. Prior to that, Mr. Insoft served in various senior executive roles at Aviv REIT, Inc. (formerly NYSE: AVIV) (&ldquo;Aviv&rdquo;),
a Chicago-based real estate investment trust that provided real estate capital and financing to the seniors housing and long term healthcare
industry, since joining the company in 2005, including as President and Chief Operating Officer from 2012 to 2015 when Aviv was acquired
by Omega, and Chief Financial Officer and Treasurer from 2009 to 2012. Mr. Insoft served as Vice President and Senior Investment Officer
of Nationwide Health Properties, Inc. (formerly NYSE: NHP), a real estate investment trust now owned by Ventas Inc., from 1998 to 2005.
Earlier in his career, Mr. Insoft served as President and Chief Financial Officer at CMI Senior Housing and Healthcare, Inc., a privately-held
seniors housing and long-term healthcare operations and development company, from 1990 to 1998. Mr. Insoft has served on the board of
directors of Home Catalyst, LLC, an investment and advisory company focused on creating housing options for the intellectually and developmentally
disabled, since July 2024. Mr. Insoft has also served as a board advisor of LifestyleCX, Inc., a company providing web-based customer
acquisition software for the seniors housing industry, since October 2022. Mr. Insoft also serves as a board director of Keshet, an organization
that provides services to the disabled community, since 2017. Mr. Insoft served on the board of directors of The National Investment Center
for Seniors Housing &amp; Care, a not-for-profit organization providing seniors housing and long-term healthcare data and research to
the institutional investment community, from 2014 to June 2023. Mr. Insoft received an M.B.A. from Columbia University and a B.S. in Electrical
Engineering from the University of Pennsylvania.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We believe that Mr. Insoft&rsquo;s
35 years of experience as a senior executive, including in senior housing, REITs, operations, and acquisitions and divestitures, coupled
with his financial expertise in the healthcare and real estate investment trust industries, make him well-qualified to serve on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>Paula J. Poskon</B>,
age 60, is the Founder and President of STOV Advisory Services LLC (&ldquo;STOV&rdquo;), a provider of professional consulting and advisory
services to company executives and institutional investors in the areas of real estate, capital markets, investor relations, and diversity
and inclusion, since 2016. Ms. Poskon served as Senior Vice President/Senior Real Estate Research Analyst at D.A. Davidson &amp; Co.,
Inc., an employee-owned full-service investment firm, from 2014 to 2015. Prior to that, Ms. Poskon was a Director and Senior Equity Research
Analyst in Real Estate at Robert W. Baird &amp; Co., Inc., an employee-owned wealth management, capital markets, asset management and
private equity firm, from 2005 to 2014. Ms. Poskon was named No. 3 on The Wall Street Journal&rsquo;s &ldquo;Best on the Street&rdquo;
among real estate analysts for 2009 and No. 2 among real estate analysts for stock-picking in 2011 by StarMine. Earlier in her career,
Ms. Poskon was an Equity Research Associate, Asset Management Associate and Investment Banking Associate at Lehman Brothers, a global
financial services firm, from 2000 to 2005. Ms. Poskon has served on the board of directors of Cedar Realty Trust, Inc. (NYSE: CDRpB and
CDRpC), a wholly owned subsidiary of real estate investment trust Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) (&ldquo;Wheeler&rdquo;),
since August 2022. Ms. Poskon served on the board of directors of Wheeler from 2019 to June 2022. Ms. Poskon also served on the boards
of trustees of Nam Tai Property, Inc. (OTCMKTS: NTPIF), a holding company, which engages in the business of real estate development and
operation, from November 2021 to June 2022, and Power REIT (NYSE:PW), a real estate investment trust that owns real estate related to
controlled environment agriculture (greenhouses), renewable energy and transportation, from July 2020 to March 2022. Ms. Poskon is a frequent
speaker at real estate industry conferences. Ms. Poskon received an M.B.A. in Finance and a B.S. in Economics with a concentration in
Accounting from the Wharton School at the University of Pennsylvania.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We believe that Ms. Poskon&rsquo;s
25 years of experience, including senior housing, REITs, investment banking, capital markets, and stockholder communications, along with
her extensive relationships and expertise in equity research and the real estate industry, make her well-qualified to serve as a director
on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>Frank J. Small</B>,
age 55, is a leader in the field of private equity real estate investment. Mr. Small is the Founder and Managing Principal of 12 North
Capital LLC, a private real estate investment and advisory firm specializing in navigating complicated transactions and complex capital
structures to maximize risk-adjusted returns, which has been his principal occupation since June 2023. Mr. Small has also served in key
leadership roles, such as Managing Director of Arcturus Group, LLC, a real estate advisory firm providing wide-ranging services to large-scale
owners and lenders across multiple asset classes nationally, since May 2020, and Investment Committee Member of Colombia Healthcare Properties,
an early-stage company backed by Jaguar Growth Partners with a strategy to execute sale-leasebacks and acquire stabilized, cash-flowing
healthcare real estate assets, since March 2019. Mr. Small served as Senior Managing Director and Head of Investments at Castle Lanterra
Properties LLC, a real estate investment company focused on acquiring assets in strategic U.S. growth markets, from May 2021 to May 2023.
Prior to that, Mr. Small served as a Senior Industry Advisor at KKR &amp; Co., Inc., a global investment firm, from September 2019 to
April 2021. Mr. Small served as Chief Investment Officer and Senior Managing Director of Greystone Healthcare Investments LLC, the healthcare
facilities platform of real estate company Greystone &amp; Co., from 2018 to 2019. Additionally, Mr. Small served as Managing Director
at GMF Capital LLC, an investment company, from 2017 to 2018, Fortress Investment Group, LLC, an investment management firm, from 2015
to 2017, and JER Partners LLC., a global real estate private equity firm, from 2005 to 2011. Mr. Small served as Senior Vice President
at Lawrence Ruben Company, Inc., a provider of real estate investment, development, management and technology, from 2003 to 2004 and
Principal of Barrow Street Capital LLC, an investment management firm, from 2000 to 2003. Mr. Small began his career as an Associate
at LaSalle Partners and Lend Lease Real Estate Investments before moving to Cerberus Real Estate Partners LLC to serve as Vice President
in 2000. Mr. Small is the founder and trustee of Brighter Night Inc., a foundation dedicated to raising awareness of and advocating for
youth and their families facing the challenges of mental health illness. Mr. Small received an M.B.A. from New York University Stern
School of Business and a B.A. in Sociology from Princeton University.</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We believe that Mr. Small&rsquo;s
25+ years of experience, including senior housing, real estate, acquisitions/divestitures, and financial restructurings, along with his
expertise in real estate investment, particularly in healthcare real estate assets, make him well-qualified to serve on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>Ivona Smith</B>, age
55, has worked with Drivetrain, LLC (&ldquo;Drivetrain&rdquo;), an independent fiduciary services firm, since 2016. Through her involvement
with Drivetrain, Ms. Smith has served as a wind-down trustee of Hollander Sleep Products, LLC, a bedding manufacturer, since 2019, liquidating
trustee of Doral Financial Corporation, a holding company of Doral Bank, since 2019, and litigation trustee of SunEdison, Inc., a renewable
energy company, since 2017. Ms. Smith served as Managing Director at Fair Oaks Capital LP, an investment advisory firm, from 2014 to 2016.
Prior to that, Ms. Smith served as Co-Founder of Restoration Capital Management LLC, an investment advisory firm, from 2001 to 2012, and
Co-Portfolio Manager at Tribeca Investments, LLC, the broker/dealer division of Citigroup/Traveler&rsquo;s, from 1999 to 2000. Earlier
in her career, Ms. Smith served as a Research Analyst at Whippoorwill Associates, Inc., a hedge fund manager, from 1998 to 1999; Senior
Consultant, Financial Advisory Services at Ernst &amp; Young LLP, a multinational professional services partnership, from 1996 to 1998;
and at Kidder, Peabody &amp; Co. Inc., a New York-based investment banking firm, as a Financial Analyst in Asset Management from 1994
to 1995 and as a Senior Financial Auditor from 1991 to 1994. Ms. Smith has served on the boards of directors of Silvergate Capital Corporation
(formerly NYSE: SI) (OTCMKTS: SICPQ), a bank holding company for chartered bank Silvergate Bank Corporation, since August 2024, Vintage
Wine Estates, Inc. (formerly NASDAQ: VWE) (OCTMKTS: VWESQ), a California-based wine company, since July 2024, and Rayonier Advanced Materials
Inc. (recently rebranded as RYAM) (NYSE: RYAM), a company recognized globally for its cellulose-based technologies, since May 2020. Ms.
Smith has also served on the board of directors of SoulCycle Inc., a fitness company, since February 2021. Previously, Ms. Smith served
as an independent manager at various companies, including Briad Restaurant Group, LLC, a franchisee of Wendy&rsquo;s International, LLC,
from November 2022 to November 2024 and June 2020 to May 2021; Francesca&rsquo;s Acquisition LLC, a multi-channel retailer, from August
2024 to September 2024; Abbyson Living LLC, a home furnishings manufacturer, from June 2024 to September 2024; Soft Surroundings Holdings,
LLC, a multi-channel retailer, from June 2023 to April 2024; CN Borrower LLC, an owner of Bitcoin mining facilities, from July 2022 to
October 2022; The Weinstein Company Holdings LLC, an independent film and television production studio, from April 2018 to February 2021;
Independent Pet Partners Holdings LLC, a pet supply retailer, from June 2020 to December 2020; and ITN Networks, LLC, a company specializing
in providing advanced technology, data, and inventory services to the television and video advertising industry, from 2017 to 2018. Ms.
Smith also served as an independent director on the boards of directors of various companies, including 2U, Inc. (formerly NASDAQ: TWOU),
an American educational technology company, from May 2024 to September 2024; CST Industries, Inc., a leader in the manufacture and construction
of factory coated metal storage tanks, aluminum domes and specialty covers, from November 2021 to July 2024; Peer Street, Inc., a real
estate investing platform, from April 2023 to May 2024; IronNet, Inc., a global cybersecurity leader, from November 2023 to February 2024;
Zymergen Inc., a biotechnology company, from June 2023 to February 2024; Phoenixus AG, a biopharmaceutical company, from August 2022 to
October 2023; Health Innovators Inc. (d/b/a/ DayToDay Health), a comprehensive care management platform, from May 2021 to November 2021;
Seegrid Holding Corp., the owner of a company specializing in material handling automation solutions, primarily focused on providing autonomous
mobile robots, from September 2020 to December 2020; and iQOR Holdings Inc., a business process outsourcing company, from March 2020 to
November 2020. Ms. Smith received an M.B.A. from New York University Stern School of Business and a B.S. in Finance from Fordham University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We believe that Ms. Smith&rsquo;s
30 years of experience, including operational and financial restructurings, along with her extensive expertise in the financial services
industry&mdash;including internal audit, risk management, restructuring advisory, valuation, and corporate finance&mdash;coupled with
her board experience, makes her well-qualified to serve on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>Steven L. Vick</B>,
age 66, is the Co-Founder and Chief Executive Officer of Signature Senior Living, LLC, a developer and operator of multiple assisted living
and memory care facilities, since 2005. Previously, Mr. Vick served as Co-Founder and Chief Executive Officer of Pegasus Senior Living
LLC (&ldquo;Pegasus&rdquo;), a Dallas-based operator of senior housing, from 2018 to April 2021. Mr. Vick served as a Consultant to Serene
Senior Living Private Limited, India, a developer of senior housing facilities, from 2012 to 2017. Starting in 2007, Mr. Vick developed
a proprietary software solution for the senior living industry, which he sold to MatrixCare in 2015. Mr. Vick served as President and
Chief Executive Officer of Assisted Living Concepts, Inc., a chain of assisted living facilities, from 2002 to 2005. Mr. Vick served as
President of Alterra Healthcare Corporation (formerly NYSE: ALHC) (&ldquo;Alterra&rdquo;), a national assisted living company, from 2001
to 2002, where he was also Chief Operating Officer from 1997 to 2001. Earlier in his career, Mr. Vick co-founded Sterling House Corporation
(formerly AMEX: SGH) (&ldquo;Sterling House&rdquo;), an assisted living company, from 1991 until its merger with Alterra in 1997. Mr.
Vick served on the boards of directors of Pegasus, from 2018 to April 2021, Assisted Living Concepts, Inc, from 2002 to 2005, Alterra
from 1997 to 2002 and Sterling House from 1995 to 1997. Mr. Vick served on the boards of directors of the American Senior Housing Association
and Assisted Living Federation of America. Mr. Vick received a B.A. from Wichita State University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We believe that Mr. Vick&rsquo;s
35 years of experience as a senior executive, including in senior housing, operations, and turnarounds, make him well-qualified to serve
on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>Lori B. Wittman</B>,
age 66, has served as Executive Vice President and Chief Financial Officer of Aventine Property Group, Inc., a privately-held real estate
investment trust, since April 2023. Ms. Wittman previously served as Interim Chief Financial Officer and Treasurer of NETSTREIT Corp.
(NYSE: NTST) (&ldquo;NETSTREIT&rdquo;), an internally managed real estate investment trust, from November 2022 to April 2023. Ms. Wittman
served as an advisor to Big Rock Partners Acquisition Corp. (&ldquo;Big Rock&rdquo;), a blank check company, from February 2020 until
its business combination in May 2021, after serving as its Chief Financial Officer from 2017 to February 2020. From 2015 to 2017, Ms.
Wittman served as the Chief Financial Officer of Care Capital Properties, Inc. (formerly NYSE: CCP), a self-administered, self-managed
real estate investment trust. Prior to that, Ms. Wittman served as Senior Vice President of Capital Markets and Investor Relations at
Ventas, Inc. (NYSE: VTR), a real estate investment trust specializing in the ownership and management of research, medicine and healthcare
facilities. Earlier in her career, Ms. Wittman served in various finance, accounting and capital markets related senior executive roles
at companies, including General Growth Properties, Inc., Big Rock Partners, LLC, Heitman Financial and Homart Development Company. Ms.
Wittman has served on the boards of directors of NETSTREIT, since 2019 and Global Medical REIT Inc. (NYSE: GMRE), a real estate investment
trust engaged primarily in the acquisition of healthcare facilities, since 2018. Previously, Ms. Wittman served on the boards of directors
of Freehold Properties Inc., a real estate investment company, from 2019 to March 2023; IMH Financial Corporation, a real estate finance
company, from 2014 until November 2020; and Big Rock, from 2017 to February 2020. Ms. Wittman also previously served on the board of
directors of Green Realty Trust, Inc., a real estate company. Ms. Wittman is a trustee of Clark University. Ms. Wittman served on the
boards of directors of Young Center for Immigrant Children&rsquo;s Rights, Midwest Hedge Funds Care and The Women&rsquo;s Treatment Center.
Ms. Wittman received an M.B.A. in Finance and Accounting from the University of Chicago, M.C.P. in Housing and Real Estate Finance from
the University of Pennsylvania and a B.A. in Geography/Sociology from Clark University.</P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We believe that Ms. Wittman&rsquo;s
30+ years extensive experience in the real estate industry, including senior housing, REITs, skilled nursing, operations and stockholder
communications, as a senior executive and through board service, coupled with her deep expertise in financial management and corporate
governance, makes her well-qualified to serve on the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The principal business
address of each of Messrs. Insoft and Vick and Ms. Poskon is a personal residence which has been retained in the files of Olshan Frome
Wolosky LLP, 1325 Avenue of the Americas, New York, New York 10019. The principal business address of Mr. Small is 680 E. Colorada Boulevard,
Suite 180, Pasadena, California 91101. The principal business address of Ms. Smith is 410 Park Ave., Suite 900, New York, New York 10022.
The principal business address of Ms. Wittman is 110 S. Wacker Dr., Suite 3350, Chicago, Illinois 60606.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Each of the Ortelius Nominees
is a citizen of the United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As of the date hereof,
none of the Ortelius Nominees owns beneficially or of record any securities of the Company and none of the Ortelius Nominees has entered
into any transactions in the securities of the Company during the past two years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Each Ortelius Nominee may
be deemed to be a member of a &ldquo;group&rdquo; with the other Participants for the purposes of Section 13(d)(3) of the Exchange Act,
and such group may be deemed to beneficially own the 2,504,155 shares of Common Stock owned in the aggregate by all of the Participants.
Each Participant disclaims beneficial ownership of the shares of Common Stock that he, she or it does not directly own.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Each Ortelius Nominee has
consented to being named as a nominee in the Nomination Notice, being named as a nominee of Pangaea Ventures (as defined below) in any
proxy statement and form of proxy relating to the Annual Meeting and serving as a director of the Company if elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Each Ortelius Nominee has
granted Peter DeSorcy a power of attorney to execute certain SEC filings and other documents in connection with the solicitation of proxies
at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Pangaea Ventures has entered
into an Engagement and Indemnification Agreement with each Ortelius Nominee (the &ldquo;Nominee Agreements&rdquo;). Pursuant to the Nominee
Agreements, among other things, each Ortelius Nominee has agreed to be a nominee of Pangaea Ventures and serve as a director of Brookdale
if elected, and Pangaea Ventures has agreed to (i) indemnify each Ortelius Nominee against any losses suffered, incurred, or sustained
by such Ortelius Nominee in connection with the solicitation of proxies from the stockholders of the Company in support of their election
to the Board, and (ii) reimburse each Ortelius Nominee for reasonable, documented, out-of-pocket expenses incurred as a result of such
Ortelius Nominee&rsquo;s nomination. For the avoidance of doubt, such indemnification does not apply to any claims made against such
Ortelius Nominees in their capacities as directors of the Company, if so elected. Each Ortelius Nominee additionally agreed pursuant
to the Nominee Agreements to consult with Pangaea Ventures regarding any purchase, sale or disposition of securities of the Company prior
to such Ortelius Nominee&rsquo;s election or appointment to the Board.</P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Mr. Insoft and OA have
entered into an advisory board agreement, dated April 11, 2024 (the &ldquo;Advisory Board Agreement&rdquo;), pursuant to which Mr. Insoft
agreed to serve on an advisory board to assist with the management of Panthalassa Ventures, L.P. (&ldquo;Panthalassa&rdquo;), a fund for
which OA serves as investment manager. As an advisory board member, Mr. Insoft would provide strategic consulting services and otherwise
provide advice as requested by OA, including on potential investments by Panthalassa or affiliated entities. Pursuant to the Advisory
Board Agreement, Mr. Insoft would be entitled to receive a fee in an amount equal to 20% of any carried interest or incentive allocation
distributions by Panthalassa to its general partner, and would be entitled to customary co-investment opportunities. Mr. Insoft also would
be entitled to reimbursement for reasonable and necessary expenses incurred in connection with his performance of services under the Advisory
Board Agreement. The Advisory Board Agreement is terminable by either party at any time upon written notice to the other party. Panthalassa
has been formed but as of the date hereof has not commenced operations. For the avoidance of doubt, the Advisory Board Agreement does
not entitle Mr. Insoft to any fees in connection with Pangaea Ventures&rsquo; investment in Brookdale or OA&rsquo;s investment management
services provided to Pangaea Ventures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We believe that each Ortelius
Nominee presently is, and if elected as a director of the Company, would qualify as, an &ldquo;independent director&rdquo; within the
meaning of (i) applicable New York Stock Exchange (&ldquo;NYSE&rdquo;) listing standards applicable to board composition and (ii) Section
301 of the Sarbanes-Oxley Act of 2002. Notwithstanding the foregoing, we acknowledge that no director of an NYSE listed company qualifies
as &ldquo;independent&rdquo; under the NYSE listing standards unless the board of directors affirmatively determines that such director
is independent under such standards. Accordingly, we acknowledge that if any Ortelius Nominee is elected, the determination of such Ortelius
Nominee&rsquo;s independence under the NYSE listing standards ultimately rests with the judgment and discretion of the Board. No Ortelius
Nominee is a member of the Company&rsquo;s compensation, nominating or audit committee that is not independent under any such committee&rsquo;s
applicable independence standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Except as set forth in
this Proxy Statement (including the Schedules hereto), (i) during the past 10 years, no Ortelius Nominee has been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors); (ii) no Ortelius Nominee directly or indirectly beneficially owns
any securities of the Company; (iii) no Ortelius Nominee owns any securities of the Company which are owned of record but not beneficially;
(iv) no Ortelius Nominee has purchased or sold any securities of the Company during the past two years; (v) no part of the purchase price
or market value of the securities of the Company owned by any Ortelius Nominee is represented by funds borrowed or otherwise obtained
for the purpose of acquiring or holding such securities; (vi) no Ortelius Nominee nor any of his or her associates is, or within the
past year was, a party to any contract, arrangements or understandings with any person with respect to any securities of the Company,
including, but not limited to, joint ventures, loan or option arrangements, puts or calls, guarantees against loss or guarantees of profit,
division of losses or profits, or the giving or withholding of proxies; (vii) no associate of any Ortelius Nominee owns beneficially,
directly or indirectly, any securities of the Company; (viii) no Ortelius Nominee owns beneficially, directly or indirectly, any securities
of any parent or subsidiary of the Company; (ix) no Ortelius Nominee nor any of his or her affiliates, associates or immediate family
members was a party to any transaction, or series of similar transactions, since the beginning of the Company&rsquo;s last fiscal year,
or is a party to any currently proposed transaction, or series of similar transactions, to which the Company or any of its subsidiaries
was or is to be a party, in which the amount involved exceeds $120,000; (x) no Ortelius Nominee nor any of his or her associates has
any arrangement or understanding with any person with respect to any future employment by the Company or its affiliates, or with respect
to any future transactions to which the Company or any of its affiliates will or may be a party; (xi) no Ortelius Nominee nor any of
his or her associates has a substantial interest, direct or indirect, by securities holdings or otherwise in any matter to be acted on
at the Annual Meeting; (xii) no Ortelius Nominee holds any positions or offices with the Company; (xiii) no Ortelius Nominee has a family
relationship with any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer;
(xiv) no companies or organizations, with which any of the Ortelius Nominees has been employed in the past five years, is a parent, subsidiary
or other affiliate of the Company; and (xv) there are no material proceedings to which any Ortelius Nominee or any of his or her associates
is a party adverse to the Company or any of its subsidiaries or has a material interest adverse to the Company or any of its subsidiaries.
Except as disclosed herein, with respect to each of the Ortelius Nominees, (a) none of the events enumerated in Item 401(f)(1)-(8) of
Regulation S-K of the Exchange Act (&ldquo;Regulation S-K&rdquo;) occurred during the past 10 years, (b) there are no relationships involving
any Ortelius Nominee or any of such Ortelius Nominee&rsquo;s associates that would have required disclosure under Item 407(e)(4) of Regulation
S-K had such Ortelius Nominee been a director of the Company, and (c) none of the Ortelius Nominees nor any of their associates has received
any fees earned or paid in cash, stock awards, option awards, non-equity incentive plan compensation, changes in pension value or nonqualified
deferred compensation earnings or any other compensation from the Company during the Company&rsquo;s last completed fiscal year, or was
subject to any other compensation arrangement described in Item 402 of Regulation S-K.</P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Other than as set forth
in this Proxy Statement, there are no agreements, arrangements or understandings between or among Ortelius and the Ortelius Nominees or
any other person or persons pursuant to which the nominations described herein are to be made, other than the consent by each of the Ortelius
Nominees to being named as a nominee of Pangaea Ventures in any proxy statement and form of proxy relating to the Annual Meeting and serving
as a director of the Company if elected. None of the Ortelius Nominees is a party adverse to the Company or any of its subsidiaries or
has a material interest adverse to the Company or any of its subsidiaries in any material pending legal proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, if five or more of the Ortelius Nominees are elected as directors to the Board such that they constitute a majority of
the Board, it would constitute a &ldquo;change of control&rdquo; under certain of the Company&rsquo;s agreements governing a material
portion of its outstanding debt, unless the Board approves the election of such nominees in advance. Please refer to the Company&rsquo;s
proxy statement for additional information. We request that the Board approve the election of the Ortelius Nominees in advance such that
their election would not trigger the change of control provisions of the agreements described in the Company&rsquo;s proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We do not expect that the
Ortelius Nominees will be unable to stand for election, but, in the event any Ortelius Nominee is unable to serve or for good cause will
not serve, the shares of Common Stock represented by the enclosed <B>WHITE</B> universal proxy card will be voted for substitute nominee(s),
to the extent this is not prohibited under the Company&rsquo;s Amended and Restated Bylaws (the &ldquo;Bylaws&rdquo;) and applicable law.
In addition, we reserve the right to nominate substitute person(s) if the Company makes or announces any changes to the Bylaws or takes
or announces any other action that has, or if consummated would have, the effect of disqualifying any Ortelius Nominee, to the extent
this is not prohibited under the Company&rsquo;s organizational documents and applicable law. In any such case, we would identify and
properly nominate such substitute nominee(s) in accordance with the Bylaws and the shares of Common Stock represented by the enclosed
<B>WHITE</B> universal proxy card will be voted for such substitute nominee(s). We reserve the right to nominate additional person(s),
to the extent this is not prohibited under the Bylaws and applicable law, if the Company increases the size of the Board above its existing
size or increases the number of directors whose terms expire at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Ortelius and Brookdale
will each be using a universal proxy card for voting on the election of directors at the Annual Meeting, which will include the names
of all nominees for election to the Board. Each of the Ortelius Nominees has consented to being named as a nominee for election as a
director of the Company in any proxy statement relating to the Annual Meeting. Stockholders will have the ability to vote for up to eight
nominees on Ortelius&rsquo; enclosed <B>WHITE</B> universal proxy card. Any stockholder who wishes to vote for any combination of the
Company&rsquo;s nominees and the Ortelius Nominees may do so on Ortelius&rsquo; enclosed <B>WHITE</B> universal proxy card. <B>There
is no need to use the Company&rsquo;s blue proxy card or voting instruction form, regardless of how you wish to vote.</B></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Stockholders are permitted
to vote for less than eight nominees or for any combination (up to eight total) of the Ortelius Nominees and the Company&rsquo;s nominees
on the <B>WHITE</B> universal proxy card. However, if stockholders choose to vote for any of the Company&rsquo;s nominees, we recommend
that stockholders vote in favor of the Unopposed Company Nominees to help achieve a Board composition that we believe is in the best interest
of all stockholders. <B>There is no need to use the Company&rsquo;s blue proxy card or voting instruction form, regardless of how you
wish to vote. </B>Ortelius urges stockholders to vote using our <B>WHITE</B> universal proxy card <B>&ldquo;FOR&rdquo; </B>all of the
Ortelius Nominees and <B>&ldquo;FOR&rdquo; </B>the Unopposed Company Nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company nominees that
Ortelius does not oppose are the Unopposed Company Nominees. Certain information about the Unopposed Company Nominees is set forth in
the Company&rsquo;s proxy statement. Ortelius is not responsible for the accuracy of any information provided by or relating to Brookdale
or its nominees contained in any proxy solicitation materials filed or disseminated by, or on behalf of, Brookdale or any other statements
that Brookdale or its representatives have made or may otherwise make.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>IF YOU MARK FEWER THAN EIGHT
 &ldquo;FOR&rdquo; BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, OUR WHITE UNIVERSAL PROXY CARD, WHEN DULY EXECUTED, WILL BE VOTED ONLY
AS DIRECTED. IF NO DIRECTION IS INDICATED WITH RESPECT TO HOW YOU WISH TO VOTE YOUR SHARES, THE PROXIES NAMED THEREIN WILL VOTE SUCH SHARES
 &ldquo;FOR&rdquo; THE SIX ORTELIUS NOMINEES AND THE TWO UNOPPOSED COMPANY NOMINEES. IMPORTANTLY, IF YOU MARK MORE THAN EIGHT &ldquo;FOR&rdquo;
BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, ALL OF YOUR VOTES FOR THE ELECTION OF DIRECTORS WILL BE DEEMED INVALID.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>WE STRONGLY URGE YOU TO VOTE
 &ldquo;FOR&rdquo; THE ELECTION OF THE ORTELIUS NOMINEES ON THE ENCLOSED <U>WHITE</U> UNIVERSAL PROXY CARD.<BR STYLE="clear: both">
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>PROPOSAL 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ADVISORY APPROVAL OF
NAMED EXECUTIVE OFFICER COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As discussed in further
detail in the Company&rsquo;s proxy statement, in accordance with the requirements of Section 14A of the Exchange Act, the Company is
providing stockholders with the opportunity to vote on a non-binding, advisory resolution to approve the compensation of the Company&rsquo;s
named executive officers as disclosed pursuant to the SEC&rsquo;s executive compensation disclosure rules. This disclosure includes the
 &ldquo;Compensation Discussion and Analysis&rdquo; provided in the Company&rsquo;s proxy statement, and the compensation tables and the
narrative discussion that accompanies the compensation tables.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Accordingly, at the Annual
Meeting, the Board will request stockholders&rsquo; advisory vote on the following resolution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 12pt; text-align: justify">RESOLVED, that the compensation paid to
the named executive officers, as disclosed in this proxy statement pursuant to the SEC&rsquo;s executive compensation disclosure rules
(which disclosure includes the Compensation Discussion and Analysis, the compensation tables and the narrative discussion that accompanies
the compensation tables), is hereby approved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, this vote is advisory, which means it is not binding on the Company and will not be construed as overruling a decision
by the Company, the Board or the Compensation Committee of the Board (the &ldquo;Compensation Committee&rdquo;) or creating or implying
any additional fiduciary duty for any of them. In addition, the vote is not intended to address any specific element of compensation,
but rather relates to the overall compensation of the Company&rsquo;s named executive officers. According to the Company&rsquo;s proxy
statement, although the vote is non-binding, the Compensation Committee values the opinions expressed by stockholders and will consider
the outcome of the vote when making future compensation decisions for named executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, the advisory approval of the Company&rsquo;s named executive officer compensation requires the majority of shares present
and entitled to vote. Abstentions will have the same effect as votes against this proposal and broker non-votes will have no effect on
this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0.5in"><B>WE MAKE NO RECOMMENDATION
WITH RESPECT TO THIS PROPOSAL AND INTEND TO VOTE OUR SHARES &ldquo;AGAINST&rdquo; THIS PROPOSAL.</B><FONT STYLE="background-color: yellow"><BR STYLE="clear: both">
</FONT></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"> <B>PROPOSAL 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center; text-indent: 0.5in"><B>RATIFICATION OF APPOINTMENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As discussed in further
detail in the Company&rsquo;s proxy statement, in accordance with its charter, the Audit Committee of the Board (the &ldquo;Audit Committee&rdquo;)
has selected the firm of Ernst &amp; Young LLP (&ldquo;Ernst &amp; Young&rdquo;) to be Brookdale&rsquo;s independent registered public
accounting firm for the year 2025 and has further directed that the Audit Committee&rsquo;s appointment of Ernst &amp; Young be submitted
for ratification by the stockholders at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, if the stockholders do not ratify this appointment, the Audit Committee will re-evaluate its appointment of Ernst &amp;
Young. A representative of Ernst &amp; Young will be present at the Annual Meeting, either in person or by teleconference, will have an
opportunity to make a statement, and will be available to respond to appropriate questions from stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, the ratification of the appointment of the independent registered public accounting firm for 2025 requires the majority
of shares present and entitled to vote. Abstentions will have the same effect as votes against this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>WE MAKE NO RECOMMENDATION WITH RESPECT TO
THIS PROPOSAL AND INTEND TO VOTE OUR SHARES &ldquo;FOR&rdquo; THIS PROPOSAL.<FONT STYLE="background-color: yellow"><BR STYLE="clear: both">
</FONT></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">VOTING AND PROXY PROCEDURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Only stockholders of record
at the close of business on the Record Date are entitled to receive notice of, attend, and vote at the Annual Meeting. Stockholders who
sell their shares of Common Stock before the Record Date (or acquire them without voting rights after the Record Date) may not vote such
shares. Stockholders of record on the Record Date will retain their voting rights in connection with the Annual Meeting even if they sell
such shares after the Record Date. Based on publicly available information, Ortelius believes that the only outstanding class of securities
of the Company entitled to vote at the Annual Meeting is the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Shares of Common Stock
represented by properly executed <B>WHITE</B> universal proxy cards will be voted at the Annual Meeting as marked and, in the absence
of specific instructions, will be voted <B>&ldquo;FOR&rdquo; </B>the election of the Ortelius Nominees and the Unopposed Company Nominees
to the Board, <B>&ldquo;AGAINST&rdquo;</B> the approval, on an advisory basis, of the Company&rsquo;s named executive officer compensation,
and <B>&ldquo;FOR&rdquo;</B> the ratification of the appointment of Ernst &amp; Young as the Company&rsquo;s independent registered public
accounting firm for 2025, and in the discretion of the persons named as proxies on all other matters as may properly come before the Annual
Meeting, as described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Ortelius and Brookdale
will each be using a universal proxy card for voting on the election of directors at the Annual Meeting, which will include the names
of all nominees for election to the Board. Stockholders will have the ability to vote for up to eight nominees on Ortelius&rsquo; enclosed
<B>WHITE</B> universal proxy card. Any stockholder who wishes to vote for any of the Company&rsquo;s nominees in addition to the Ortelius
Nominees may do so on Ortelius&rsquo; <B>WHITE</B> universal proxy card. <B>While, there is no need to use the Company&rsquo;s blue proxy
card or voting instruction form, regardless of how you wish to vote, you may still vote &ldquo;FOR&rdquo; the Ortelius Nominees on the
Company&rsquo;s blue proxy card or blue voting instruction form. Only your latest dated vote counts.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Stockholders are permitted
to vote for less than eight nominees or for any combination (up to eight total) of the Ortelius Nominees and the Company&rsquo;s nominees
on the <B>WHITE</B> universal proxy card. However, if stockholders choose to vote for any of the Company&rsquo;s nominees, we recommend
that stockholders vote in favor of the Unopposed Company Nominees to help achieve a Board composition that we believe is in the best interest
of all stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We recommend that stockholders
do not vote for any of the Company&rsquo;s nominees other than the Unopposed Company Nominees. Among other potential consequences, voting
for Company nominees other than the Unopposed Company Nominees may result in the failure of one or more of the Ortelius Nominees to be
elected to the Board. We believe that voting on the <B>WHITE</B> universal proxy card provides the best opportunity for stockholders to
elect all of the Ortelius Nominees and achieve the best Board composition overall. Ortelius therefore urges stockholders to use our <B>WHITE</B>
universal proxy card to vote <B>&ldquo;FOR&rdquo;</B> the six Ortelius Nominees and <B>&ldquo;FOR&rdquo;</B> the two Unopposed Company
Nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>IMPORTANTLY, IF YOU
MARK MORE THAN EIGHT &ldquo;FOR&rdquo; BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, ALL OF YOUR VOTES FOR THE ELECTION OF DIRECTORS
WILL BE DEEMED INVALID.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>IF YOU MARK FEWER THAN
EIGHT &ldquo;FOR&rdquo; BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, OUR WHITE UNIVERSAL PROXY CARD, WHEN DULY EXECUTED, WILL BE VOTED
ONLY AS DIRECTED. IF NO DIRECTION IS INDICATED WITH RESPECT TO HOW YOU WISH TO VOTE YOUR SHARES, THE PROXIES NAMED THEREIN WILL VOTE SUCH
SHARES &ldquo;FOR&rdquo; THE SIX ORTELIUS NOMINEES AND THE TWO UNOPPOSED COMPANY NOMINEES.</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">QUORUM; BROKER NON-VOTES; DISCRETIONARY VOTING</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A quorum is the minimum number
of shares of Common Stock that must be represented at a duly called meeting in person or by proxy in order to legally conduct business
at the meeting. According to the Company&rsquo;s proxy statement, the presence at the Annual Meeting, in person or by proxy, of the holders
of a majority of the shares of Common Stock issued and outstanding on the Record Date will constitute a quorum for the transaction of
business. At the close of business on the Record Date, there were ________ shares of Common Stock outstanding and entitled to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Abstentions and broker non-votes
will be counted for the purpose of determining the presence of a quorum. However, if you hold your shares in street name and do not provide
voting instructions to your broker, your shares will not be voted on any proposal on which your broker does not have discretionary authority
to vote (a &ldquo;broker non-vote&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If you are a stockholder of record,
you must deliver your vote by internet, telephone or mail or attend the Annual Meeting and vote in order to be counted in the determination
of a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">If you are a beneficial owner,
your broker will vote your shares pursuant to your instructions, and those shares will count in the determination of a quorum. A broker
non-vote occurs when a broker holding shares for a beneficial owner has discretionary authority to vote on &ldquo;routine&rdquo; matters
brought before a stockholder meeting, but the beneficial owner of the shares fails to provide the broker with specific instructions on
how to vote on any &ldquo;non-routine&rdquo; matters brought to a vote at the stockholder meeting. Under the rules governing brokers&rsquo;
discretionary authority, if a stockholder receives proxy materials from or on behalf of both us and the Company, then brokers holding
shares in such stockholder&rsquo;s account will not be permitted to exercise discretionary authority regarding any of the proposals to
be voted on at the Annual Meeting, whether &ldquo;routine&rdquo; or not. As a result, there would be no broker non-votes by such brokers.
In such case, if you do not submit any voting instructions to your broker, then your shares will not be counted in determining the outcome
of any of the proposals at the Annual Meeting, nor will your shares be counted for purposes of determining whether a quorum exists. However,
if you receive proxy materials only from one of the Company and Ortelius, then brokers will be entitled to vote your shares on &ldquo;routine&rdquo;
matters without instructions from you. The only proposal that would be considered &ldquo;routine&rdquo; in such event is Proposal 3 (the
ratification of the appointment of Ernst &amp; Young as the Company&rsquo;s independent registered public accounting firm for 2025). A
broker will not be entitled to vote your shares on any &ldquo;non-routine&rdquo; matters, absent instructions from you. We urge you to
instruct your broker about how you wish your shares to be voted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">VOTES REQUIRED FOR APPROVAL</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>Election of Directors </I>&boxh;
According to the Company&rsquo;s proxy statement, as the number of director nominees at the Annual Meeting will exceed the number of directors
to be elected, the directors will be elected by a plurality of the votes cast. This means the eight directors receiving the highest number
of affirmative votes will be elected as directors of the Company. Abstentions and broker non-votes will have no effect on the election
of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>Advisory Vote on Executive
Officer Compensation</I> &boxh; According to the Company&rsquo;s proxy statement, the approval, on an advisory basis, of the Company&rsquo;s
named executive officer compensation requires the majority of shares present and entitled to vote on this proposal. Abstentions will have
the same effect as votes against this proposal. Broker non-votes will have no effect on the outcome of the vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>Ratification of Independent
Registered Public Accounting Firm</I> &boxh; According to the Company&rsquo;s proxy statement, the ratification of the selection of Ernst
 &amp; Young as the Company&rsquo;s independent registered public accounting firm for the year 2025 requires the majority of shares present
and entitled to vote on this proposal. Abstentions will have the same effect as votes against this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under applicable Delaware law,
appraisal rights are not applicable to the voting on any matter to be considered at the Annual Meeting. If you sign and submit your <B>WHITE</B>
universal proxy card without specifying how you would like your shares voted, your shares will be voted in accordance with Ortelius&rsquo;
recommendations specified herein and in accordance with the discretion of the persons named on the <B>WHITE</B> universal proxy card with
respect to any other matters that may be voted upon at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">REVOCATION OF PROXIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Stockholders of the Company
may revoke their proxies at any time prior to exercise by attending the Annual Meeting and voting in person (although, attendance at the
Annual Meeting will not in and of itself constitute revocation of a proxy) or by delivering a written notice of revocation. The delivery
of a subsequently dated proxy which is properly completed will constitute a revocation of any earlier proxy. The revocation may be delivered
either to Ortelius in care of Saratoga at the address set forth on the back cover of this Proxy Statement or to the Company&rsquo;s Secretary
at 105 Westwood Place, Suite 400, Brentwood, Tennessee 37027 or any other address provided by the Company. Although a revocation is effective
if delivered to the Company, we request that either the original or photostatic copies of all revocations be mailed to Ortelius in care
of Saratoga at the address set forth on the back cover of this Proxy Statement so that we will be aware of all revocations and can more
accurately determine if and when proxies have been received from the holders of record on the Record Date of a majority of the shares
entitled to be voted at the Annual Meeting. Additionally, Saratoga may use this information to contact stockholders who have revoked their
proxies in order to solicit later dated proxies for the election of the Ortelius Nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>IF YOU WISH TO VOTE FOR THE ELECTION OF
THE ORTELIUS NOMINEES TO THE BOARD, PLEASE SIGN, DATE AND RETURN PROMPTLY THE ENCLOSED <U>WHITE</U> UNIVERSAL PROXY CARD IN THE POSTAGE-PAID
ENVELOPE PROVIDED.</B></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">SOLICITATION OF PROXIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The solicitation of proxies
pursuant to this Proxy Statement is being made by Ortelius. Proxies may be solicited by mail, facsimile, telephone, Internet, in person
and by advertisements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Ortelius has entered into
an agreement with Saratoga for solicitation and advisory services in connection with this solicitation, for which Saratoga will receive
a fee not to exceed $150,000, together with reimbursement for its reasonable out-of-pocket expenses, and will be indemnified against certain
liabilities and expenses, including certain liabilities under the federal securities laws. Saratoga will solicit proxies from individuals,
brokers, banks, bank nominees and other institutional holders. Saratoga has requested banks, brokerage houses and other custodians, nominees
and fiduciaries to forward all solicitation materials to the beneficial owners of the shares of Common Stock they hold of record. Ortelius
will reimburse these record holders for their reasonable out-of-pocket expenses in so doing. In addition, directors, officers, members
and certain other employees of Ortelius may solicit proxies as part of their duties in the normal course of their employment without any
additional compensation. It is anticipated that Saratoga will employ approximately ____ persons to solicit stockholders for the Annual
Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The entire expense of soliciting
proxies is being borne by Ortelius. Costs of this solicitation of proxies are currently estimated to be approximately $________ (including,
but not limited to, fees for attorneys, solicitors and other advisors, and other costs incidental to the solicitation). Ortelius estimates
that through the date hereof its expenses in connection with this solicitation are approximately $________. To the extent legally permissible,
if Ortelius is successful in its proxy solicitation, Ortelius intends to seek reimbursement from the Company for the expenses it incurs
in connection with this solicitation. Ortelius does not intend to submit the question of such reimbursement to a vote of security holders
of the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">ADDITIONAL PARTICIPANT INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The &ldquo;Participants&rdquo;
in the proxy solicitation are OA, Pangaea Ventures, L.P., a Delaware limited partnership (&ldquo;Pangaea Ventures&rdquo;), Ortelius Advisors
GP I, LLC, a Delaware limited liability company (&ldquo;OA GP&rdquo;), Peter DeSorcy and the Ortelius Nominees (each, a &ldquo;Participant&rdquo;
and, collectively, the &ldquo;Participants&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The principal business
address of each of OA, Pangaea Ventures, OA GP, and Mr. DeSorcy is 767 Fifth Avenue, 15<SUP>th</SUP> Floor, New York, New York 10153.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The principal business
of OA is serving as the investment advisor and manager of Pangaea Ventures. The principal business of Pangaea Ventures is serving as a
private investment vehicle. The principal business of OA GP is serving as the general partner of Pangaea Ventures. Mr. DeSorcy is the
control person of OA and certain related entities. Mr. DeSorcy is a citizen of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">As of the date hereof,
Pangaea Ventures directly beneficially owns 2,504,155 shares of Common Stock. OA, as the investment advisor and manager of Pangaea Ventures,
may be deemed the beneficial owner of the 2,504,155 shares of Common Stock owned by Pangaea Ventures. OA GP, as the general partner of
Pangaea Ventures, may be deemed the beneficial owner of the 2,504,155 shares of Common Stock owned by Pangaea Ventures. Mr. DeSorcy, as
the control person of OA, may be deemed the beneficial owner of the 2,504,155 shares of Common Stock owned by Pangaea Ventures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Each Participant may be
deemed to be a member of a &ldquo;group&rdquo; with the other Participants for the purposes of Section 13(d)(3) of the Exchange Act,
and such group may be deemed to beneficially own the 2,504,155 shares of Common Stock owned in the aggregate by all of the Participants.
Each Participant disclaims beneficial ownership of the shares of Common Stock that he, she or it does not directly own. For information
regarding transactions in securities of the Company during the past two years by the Participants, please see <U>Schedule I</U> attached
hereto. The shares of Common Stock purchased by Pangaea Ventures were purchased with working capital (which may, at any given time, include
margin loans made by brokerage firms in the ordinary course of business).</P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Except as set forth in
this Proxy Statement (including the Schedules hereto), (i) during the past 10 years, no Participant has been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors); (ii) no Participant directly or indirectly beneficially owns any securities of
the Company; (iii) no Participant owns any securities of the Company which are owned of record but not beneficially; (iv) no Participant
has purchased or sold any securities of the Company during the past two years; (v) no part of the purchase price or market value of the
securities of the Company owned by any Participant is represented by funds borrowed or otherwise obtained for the purpose of acquiring
or holding such securities; (vi) no Participant is, or within the past year was, a party to any contract, arrangements or understandings
with any person with respect to any securities of the Company, including, but not limited to, joint ventures, loan or option arrangements,
puts or calls, guarantees against loss or guarantees of profit, division of losses or profits, or the giving or withholding of proxies;
(vii) no associate of any Participant owns beneficially, directly or indirectly, any securities of the Company; (viii) no Participant
owns beneficially, directly or indirectly, any securities of any parent or subsidiary of the Company; (ix) no Participant or any of his,
her or its associates or immediate family members was a party to any transaction, or series of similar transactions, since the beginning
of the Company&rsquo;s last fiscal year, or is a party to any currently proposed transaction, or series of similar transactions, to which
the Company or any of its subsidiaries was or is to be a party, in which the amount involved exceeds $120,000; (x) no Participant or any
of his, her or its associates has any arrangement or understanding with any person with respect to any future employment by the Company
or its affiliates, or with respect to any future transactions to which the Company or any of its affiliates will or may be a party; (xi)
no Participant has a substantial interest, direct or indirect, by securities holdings or otherwise in any matter to be acted on at the
Annual Meeting; (xii) no Participant holds any positions or offices with the Company; (xiii) no Participant has a family relationship
with any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer, (xiv) no
companies or organizations, with which any of the Participants has been employed in the past five years, is a parent, subsidiary or other
affiliate of the Company; and (xv) there are no material proceedings to which any Participant or any of his, her or its associates is
a party adverse to the Company or any of its subsidiaries or has a material interest adverse to the Company or any of its subsidiaries.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">OTHER MATTERS AND ADDITIONAL INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Ortelius is unaware of any other
matters to be considered at the Annual Meeting. However, should other matters, which Ortelius is not aware of at a reasonable time before
this solicitation, be brought before the Annual Meeting, the persons named as proxies on the enclosed <B>WHITE </B>universal proxy card
will vote on such matters in their discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Some banks, brokers and other
nominee record holders may be participating in the practice of &ldquo;householding&rdquo; proxy statements and annual reports. This means
that only one copy of this Proxy Statement may have been sent to multiple stockholders in your household. We will promptly deliver a
separate copy of the document to you if you write to our proxy solicitor, Saratoga, at the address set forth on the back cover of this
Proxy Statement, or call toll free at (888) 368-0379. If you want to receive separate copies of our proxy materials in the future, or
if you are receiving multiple copies and would like to receive only one copy for your household, you should contact your bank, broker
or other nominee record holder, or you may contact our proxy solicitor at the above address and phone number.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Proxy Statement is
dated __________, 2025. You should not assume that the information contained in this Proxy Statement is accurate as of any date other
than such date, and the mailing of this Proxy Statement to stockholders shall not create any implication to the contrary.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">STOCKHOLDER PROPOSALS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, proposals of stockholders (other than director nominations) intended to be included in the Company&rsquo;s proxy statement
and form of proxy for the 2026 Annual Meeting must be received by the Company no later than ___________, 2026 and must meet the requirements
as to form and substance set forth in the rules and regulations of the SEC, including Rule 14a-8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, director nominations of stockholders intended to be included in the Company&rsquo;s proxy statement and form of proxy
card for the 2026 Annual Meeting under the proxy access provisions of the Bylaws must be received at the Company&rsquo;s principal executive
offices no earlier than _________, 2026 and no later than _________, 2026 (i.e., not less than 120 days nor more than 150 days prior to
the first anniversary of the date the Company commenced mailing of its definitive proxy statement for the Annual Meeting). If the 2026
Annual Meeting is called for a date that is not within 30 days before or after _________, 2026 (i.e., the first anniversary of the Annual
Meeting date), notice of such director nominations must be received at the Company&rsquo;s principal executive offices no earlier than
150 days before the 2026 Annual Meeting and no later than the later of 120 days before the 2026 Annual Meeting or the 10<SUP>th</SUP>
day following the day on which public announcement of the date of the 2026 Annual Meeting is first made by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">According to the Company&rsquo;s
proxy statement, proposals and director nominations of stockholders intended to be considered at the 2026 Annual Meeting, other than by
means of inclusion in the Company&rsquo;s proxy statement and form of proxy card under Rule 14a-8 and the Company&rsquo;s proxy access
bylaws, must be received at the Company&rsquo;s principal executive offices no earlier than _________, 2026 and no later than the close
of business on _________, 2026 (i.e., not less than 90 days nor more than 120 days prior to the first anniversary of the date of the Annual
Meeting). If the 2026 Annual Meeting is called for a date that is not within 25 days before or after _________, 2026 (i.e., the first
anniversary of the Annual Meeting date), the notice of stockholder nominations or proposals must be received at the Company&rsquo;s principal
executive offices no earlier than the close of business on the 90<SUP>th</SUP> day prior to the 2026 Annual Meeting and not later than
the close of business on the later of the 60<SUP>th</SUP> day prior to the 2026 Annual Meeting or the 10<SUP>th</SUP> day following the
day on which such notice of the date of the 2026 Annual Meeting is mailed or such public disclosure of the date of the 2026 Annual Meeting
is made, whichever first occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">In addition to satisfying
the foregoing requirements under the Bylaws, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support
of director nominees other than the Company&rsquo;s director nominees must provide notice that sets forth the information required by
Rule 14a-19 under the Exchange Act no later than _________, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The information set forth
above regarding the procedures for submitting stockholder proposals for consideration at the 2026 Annual Meeting is based on information
contained in the Company&rsquo;s proxy statement and the Bylaws. The incorporation of this information in this Proxy Statement should
not be construed as an admission by any of the Participants that such procedures are legal, valid or binding.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">INCORPORATION BY REFERENCE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">WE HAVE OMITTED FROM THIS
PROXY STATEMENT CERTAIN DISCLOSURE REQUIRED BY APPLICABLE LAW THAT IS EXPECTED TO BE INCLUDED IN THE COMPANY&rsquo;S PROXY STATEMENT RELATING
TO THE ANNUAL MEETING BASED ON OUR RELIANCE ON RULE 14A-5(C) UNDER THE EXCHANGE ACT. THIS DISCLOSURE IS EXPECTED TO INCLUDE, AMONG OTHER
THINGS, CURRENT BIOGRAPHICAL INFORMATION ON THE COMPANY&rsquo;S DIRECTORS AND EXECUTIVE OFFICERS, INFORMATION CONCERNING EXECUTIVE COMPENSATION
AND DIRECTOR COMPENSATION, INFORMATION CONCERNING THE COMMITTEES OF THE BOARD AND OTHER INFORMATION CONCERNING THE BOARD, INFORMATION
CONCERNING CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS, INFORMATION ABOUT THE COMPANY&rsquo;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM AND OTHER IMPORTANT INFORMATION. <B>STOCKHOLDERS ARE DIRECTED TO REFER TO THE COMPANY&rsquo;S PROXY STATEMENT FOR THE FOREGOING INFORMATION,
INCLUDING INFORMATION REQUIRED BY ITEM 7 OF SCHEDULE 14A WITH REGARD TO THE COMPANY&rsquo;S NOMINEES. STOCKHOLDERS CAN ACCESS THE COMPANY&rsquo;S
PROXY STATEMENT AND OTHER RELEVANT DOCUMENTS DISCLOSING THIS INFORMATION, WITHOUT COST, ON THE SEC&rsquo;S WEBSITE AT WWW.SEC.GOV</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">SEE <U>SCHEDULE II</U> FOR INFORMATION
REGARDING PERSONS WHO BENEFICIALLY OWN MORE THAN 5% OF THE SHARES AND THE OWNERSHIP OF THE SHARES BY THE DIRECTORS AND MANAGEMENT OF THE
COMPANY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The information concerning
the Company contained in this Proxy Statement and the Schedules attached hereto has been taken from, or is based upon, publicly available
documents on file with the SEC and other publicly available information. Although we have no knowledge that would indicate that statements
relating to the Company contained in this Proxy Statement, in reliance upon publicly available information, are inaccurate or incomplete,
to date we have not had access to the books and records of the Company, were not involved in the preparation of such information and statements
and are not in a position to verify such information and statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Your vote is important. No matter how many
or how few shares of Common Stock you own, please vote to elect the Ortelius Nominees by marking, signing, dating and mailing the enclosed
WHITE universal proxy card promptly.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.5in 0 12pt 4in"><B>Ortelius Advisors, L.P.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 4in">___________<B>, 2025</B></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><U>SCHEDULE I</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>TRANSACTIONS IN SECURITIES OF <FONT STYLE="font-family: Times New Roman, Times, Serif">THE
COMPANY</FONT><BR>
DURING THE PAST TWO YEARS</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><U>Nature of Transaction</U></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Securities<BR>
<U>Acquired/(Disposed)</U></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Date of<BR>
<U>Acquisition/Disposition</U></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"><B><U>PANGAEA VENTURES, L.P.</U></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 33%; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2,000</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">10/09/2023</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">150,000</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/11/2024</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">150,000</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/12/2024</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">150,000</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/13/2024</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">150,000</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/14/2024</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">5,455</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/18/2024</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">3,748</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">11/19/2024</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">75,000</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">12/04/2024</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">75,000</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">12/05/2024</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">75,000</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">12/06/2024</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">250,000</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">12/19/2024</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">225,000</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/07/2025</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">75,900</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/08/2025</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">100,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/10/2025</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">75,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/13/2025</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">75,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/14/2025</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">104,406</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/15/2025</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">175,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/16/2025</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">50,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/17/2025</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">12,646</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/21/2025</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">75,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/22/2025</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">50,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/23/2025</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">50,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/28/2025</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">150,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">01/29/2025</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">50,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/03/2025</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">50,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/12/2025</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">Purchase of Common Stock</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">100,000</TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">02/21/2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<!-- Field: Page; Sequence: 33; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><U>SCHEDULE II</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><I>The following table is reprinted from
the Company&rsquo;s preliminary proxy statement filed with the SEC on April 30, 2025.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Stock Ownership Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The following table sets forth, as of [&#9679;],
2025, the total number of shares of our common stock beneficially owned, and the percent so owned, by (1) each person known by us to beneficially
own more than 5% of our common stock, (2) each of our directors and named executive officers and (3) all current directors and executive
officers as a group, based on [&#9679;] shares of our common stock outstanding as of that date (excluding RSUs and restricted shares,
other than with respect to outstanding awards scheduled to vest within 60 days of that date for the respective individuals as described
in footnote 1 below). Unless otherwise indicated, each of the beneficial owners listed has, to the Company&rsquo;s knowledge, sole voting
and investment power with respect to the indicated shares of common stock. Unless otherwise indicated, the address of each person named
in the table is c/o Brookdale Senior Living Inc., 105 Westwood Place, Suite 400, Brentwood, Tennessee 37027.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 60%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid"><B>Name of Beneficial Owner</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Number of Shares</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Percentage</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>Named Executive Officers and Directors <SUP>(1)</SUP></B></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Denise W. Warren</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[201,104]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Dawn L. Kussow</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[116,766]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Chad C. White</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[307,848]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">H. Todd Kaestner</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[243,860]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">George T. Hicks</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[291,125]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Jordan R. Asher</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[139,633]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Frank M. Bumstead</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[532,506]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Claudia N. Drayton</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[31,455]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Mark Fioravanti</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[&mdash;]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Victoria L. Freed</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[169,716]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Joshua Hausman</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[&mdash;]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Elizabeth B. Mace</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[31,455]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Lee S. Wielansky</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[233,836]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Lucinda M. Baier <SUP>(2)</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[2,196,899]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">All current executive officers and directors as a group (16 persons)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[2,443,563]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[&#9679;]%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>5% Stockholders</B></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">The Vanguard Group <SUP>(3)</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[18,051,166]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[&#9679;]%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Camber Capital Management <SUP>(4)</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[17,168,525]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[&#9679;]%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Deerfield Partners, L.P. <SUP>(5)</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[14,793,264]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[&#9679;]%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">BlackRock, Inc. <SUP>(6)</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[14,518,120]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[&#9679;]%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 8.25pt">Flat Footed LLC <SUP>(7)</SUP></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[11,401,757]</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">[&#9679;]%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 34; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">*</TD><TD STYLE="text-align: justify">Less than 1%</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">Consists of shares of common stock held as of [&#9679;], 2025; the following number of vested RSUs, which
were issued at the director&rsquo;s election in lieu of a portion of quarterly cash compensation or the annual grant of immediately vested
shares for service as a director: Dr. Asher&mdash;23,214; Mr. Bumstead&ndash;51,998; and Ms. Freed&ndash;26,522; and the following number
of restricted shares, which are eligible to vest on June 18, 2025, the one year anniversary of the directors&rsquo; election to the Board:
Ms. Drayton&mdash;13,986 and Ms. Mace&mdash;13,986. The reported amounts exclude the following number of RSUs outstanding as of [&#9679;],
2025 (assuming target performance for performance-based RSUs with performance periods that have not been completed): Ms. Kussow&ndash;539,840;
Mr. White&ndash;381,627; Mr. Kaestner&ndash;266,885; Mr. Hicks&mdash;165,212; and all current executive officers as a group (excluding
Ms. Warren)&ndash;1,705,566. The reported amounts for Ms. Warren exclude 158,730 RSUs outstanding as of [&#9679;], 2025, which may vest
as described under &ldquo;Compensation Discussion and Analysis&mdash;2025 Compensation Decisions&rdquo; above. The reported amounts for
Mr. Fioravanti exclude 16,026 restricted shares, which are eligible to vest on April 13, 2026, the one year anniversary of his election
to the Board. The reported amounts for Ms. Baier exclude the following number of performance-based RSUs that remain outstanding following
her departure on April 13, 2025 (assuming the actual level of performance for completed performance periods and target performance for
RSUs with a performance period that has not been completed): 538,598. Ms. Baier&rsquo;s and Mr. White&rsquo;s reported ownership includes
unrestricted shares held in a joint account with her or his spouse.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">On April 13, 2025, Ms. Baier ceased serving as our President and Chief Executive Officer and as a member
of the Board.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">Information regarding The Vanguard Group (&ldquo;Vanguard&rdquo;) is based solely on a Schedule 13G/A
filed with the SEC on February 13, 2024 by Vanguard. Vanguard reported that it has shared voting power with respect to 114,749 shares,
sole dispositive power with respect to 17,774,545 shares and shared dispositive power with respect to 276,621 shares. The address of the
principal business office of Vanguard is 100 Vanguard Blvd., Malvern, PA 19355.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">Information regarding Camber Capital Management LP (&ldquo;Camber&rdquo;) is based solely on a Schedule
13G/A filed with the SEC on February 14, 2025 by Camber and Stephen DuBois. Camber reported that it has shared voting and shared dispositive
power with respect to the shares reported in the table. The address of the principal business office of Camber is 101 Huntington Avenue,
Suite 2101, Boston, MA 02199.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(5)</TD><TD STYLE="text-align: justify">Information regarding Deerfield Partners, L.P. (&ldquo;Deerfield&rdquo;) is based solely on a Schedule
13G/A filed with the SEC on February 12, 2024 by Deerfield, James E. Flynn, Deerfield Management Company, L.P. and Deerfield Mgmt, L.P.
Deerfield reported that it has shared voting power and shared dispositive power with respect to the shares reported in the table. The
address of the principal business office of Deerfield is 345 Park Avenue South, 12th Floor, New York, NY 10010.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(6)</TD><TD STYLE="text-align: justify">Information regarding BlackRock, Inc. (&ldquo;BlackRock&rdquo;) is based solely on a Schedule 13G/A filed
with the SEC on April 17, 2025 by BlackRock. BlackRock reported that it has sole voting power with respect to 14,295,912 shares and sole
dispositive power with respect to 14,518,120 shares. The address of the principal business office of BlackRock is 50 Hudson Yards, New
York, NY 10001.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(7)</TD><TD STYLE="text-align: justify">Information regarding Flat Footed LLC (&ldquo;Flat Footed&rdquo;) is based solely on a Schedule 13G/A
filed on February 14, 2025 by Flat Footed and Marc Andersen. Flat Footed reported that it has shared voting power and shared dispositive
power with respect to the shares in the table. The address of the principal business office of Flat Footed is 3415 North Pines Way, Suite
205, Wilson, WY 83014.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">IMPORTANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Tell the Board what you
think! Your vote is important. No matter how many or few shares of Common Stock you own, please give us your proxy <B>FOR</B> the election
of the Ortelius Nominees and in accordance with our recommendations on the other proposals on the agenda for the Annual Meeting by taking
three steps:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">SIGNING the enclosed <B>WHITE</B> universal proxy card;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">DATING the enclosed <B>WHITE</B> universal proxy card; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">MAILING the enclosed <B>WHITE</B> universal proxy card TODAY in the envelope provided (no postage is required
if mailed in the United States).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>VOTING BY INTERNET using the unique &#8220;control number&#8221; and following the instructions that appear on your <B>WHITE</B> universal
proxy card.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">You may vote your shares
in person at the Annual Meeting; however, even if you plan to attend the Annual Meeting in person, we recommend that you submit your <B>WHITE</B>
universal proxy card by mail by the applicable deadline so that your vote will still be counted if you later decide not to attend the
Annual Meeting. <B>If any of your shares of Common Stock are held in the name of a brokerage firm, bank, bank nominee or other institution,
only it can vote such shares of Common Stock and only upon receipt of your specific instructions.</B> Depending upon your broker or custodian,
you should be able to vote either by toll-free telephone or by the Internet. Please refer to the enclosed voting form for instructions
on how to vote electronically. You may also vote by signing, dating and returning the enclosed <B>WHITE</B> universal voting form and
returning it in the enclosed pre-paid return envelope.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">If you have any questions
or require any additional information concerning this Proxy Statement, please contact Saratoga as set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; border: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>If you have any questions, require assistance in
    voting your </I><B>WHITE</B> <I>universal proxy card,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>or need additional copies of Ortelius&rsquo; proxy
    materials,</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>please contact:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_003.jpg" ALT="Saratoga Proxy Consulting, LLC" STYLE="height: 54px; width: 206px"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">520 8th Avenue, 14th Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">New York, NY 10018</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(212) 257-1311</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(888) 368-0379</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">info@saratogaproxy.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 36; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><B>WHITE</B> UNIVERSAL PROXY CARD</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="color: red">PRELIMINARY COPY SUBJECT
TO COMPLETION<BR>
DATED MAY 5</FONT><FONT STYLE="color: #ED0000">, </FONT><FONT STYLE="color: red">2025</FONT><BR>
<BR>
BROOKDALE SENIOR LIVING INC.<BR>
<BR>
2025 ANNUAL MEETING OF STOCKHOLDERS<BR>
<BR>
THIS PROXY IS SOLICITED ON BEHALF OF<BR>
ORTELIUS ADVISORS, L.P. AND THE OTHER PARTICIPANTS IN ITS SOLICITATION<BR>
<BR>
THE BOARD OF DIRECTORS OF BROOKDALE SENIOR LIVING INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">IS NOT SOLICITING THIS PROXY<BR>
<BR>
P&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;O&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;X&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Y</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 0.5in">The undersigned appoints
Peter DeSorcy, Kenneth Mantel and John Ferguson and each of them, attorneys and agents with full power of substitution to vote all shares
of common stock of Brookdale Senior Living Inc. (the &ldquo;Company&rdquo;) which the undersigned would be entitled to vote if personally
present at the 2025 annual meeting of stockholders of the Company scheduled to be held on ______, 2025 at ______ Central Time at ___________
(including any adjournments, postponements or continuations thereof and any meeting which may be called in lieu thereof, the &ldquo;Annual
Meeting&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The undersigned hereby
revokes any other proxy or proxies heretofore given to vote or act with respect to the shares of common stock of the Company held by the
undersigned and hereby ratifies and confirms all action the herein named attorneys and proxies, their substitutes, or any of them may
lawfully take by virtue hereof. If properly executed, this Proxy will be voted as directed on the reverse and in the discretion of the
herein named attorneys and proxies or their substitutes with respect to any other matters as may properly come before the Annual Meeting
that are unknown to Ortelius Advisors, L.P. (together with the other participants in its solicitation, &ldquo;Ortelius&rdquo;) a reasonable
time before this solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>THIS PROXY WILL BE VOTED
AS DIRECTED. IF NO DIRECTION IS INDICATED WITH RESPECT TO THE PROPOSALS ON THE REVERSE, THIS PROXY WILL BE VOTED &ldquo;FOR&rdquo; THE
SIX ORTELIUS NOMINEES AND &ldquo;FOR&rdquo; TWO COMPANY NOMINEES UNOPPOSED BY ORTELIUS IN PROPOSAL 1, &ldquo;AGAINST&rdquo; PROPOSAL 2,
AND &ldquo;FOR&rdquo; PROPOSAL 3.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">This Proxy will be valid
until the completion of the Annual Meeting. This Proxy will only be valid in connection with Ortelius&rsquo; solicitation of proxies for
the Annual Meeting.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">PLEASE SIGN, DATE AND MAIL THIS PROXY
CARD PROMPTLY!<BR>
<BR>
CONTINUED AND TO BE SIGNED ON REVERSE SIDE</P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><B>WHITE</B> UNIVERSAL PROXY CARD</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>[X] Please mark vote as in this example</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ORTELIUS
</B></FONT><B>STRONGLY RECOMMENDS THAT STOCKHOLDERS VOTE <FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;FOR&rdquo; </FONT>THE
SIX ORTELIUS NOMINEES AND &ldquo;FOR&rdquo; TWO COMPANY NOMINEES UNOPPOSED BY ORTELIUS, AND NOT TO VOTE &ldquo;FOR&rdquo; ANY OF THE REMAINING
COMPANY NOMINEES LISTED BELOW IN PROPOSAL 1.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>YOU MAY SUBMIT VOTES &ldquo;FOR&rdquo; UP
TO EIGHT (8) NOMINEES. IMPORTANTLY, IF YOU MARK MORE THAN EIGHT (8) &ldquo;FOR&rdquo; BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS,
ALL OF YOUR VOTES &ldquo;FOR&rdquo; THE ELECTION OF DIRECTORS WILL BE DEEMED INVALID. IF YOU MARK FEWER THAN EIGHT (8) &ldquo;FOR&rdquo;
BOXES WITH RESPECT TO THE ELECTION OF DIRECTORS, THIS PROXY CARD, WHEN DULY EXECUTED, WILL BE VOTED ONLY AS DIRECTED.</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company&rsquo;s
next annual meeting of stockholders and until his or her successor has been duly elected and qualified.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 56%; border: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ORTELIUS NOMINEES</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FOR</B></FONT></TD>
    <TD STYLE="width: 24%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WITHHOLD</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(a) Steven J. Insoft</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(b) Paula J. Poskon</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(c) Frank J. Small</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(d) Ivona Smith</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(e) Steven L. Vick</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(f) Lori B. Wittman</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 56%; border: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>COMPANY NOMINEES UNOPPOSED BY ORTELIUS </B></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FOR</B></FONT></TD>
    <TD STYLE="width: 24%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WITHHOLD</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(a) _______________</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">(b) _______________</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 56%; border: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>COMPANY NOMINEES OPPOSED BY ORTELIUS </B></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FOR</B></FONT></TD>
    <TD STYLE="width: 24%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WITHHOLD</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(a) _______________</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(b) _______________</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(c) _______________</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(d) _______________</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(e) _______________</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">(f) _______________</TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"><B>WHITE</B> UNIVERSAL PROXY CARD</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify"><B>ORTELIUS MAKES NO RECOMMENDATION WITH RESPECT
TO PROPOSAL 2.</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">The Company&rsquo;s advisory proposal to approve the Company&rsquo;s named executive officer compensation.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> FOR</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> AGAINST</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> ABSTAIN</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify"><B>ORTELIUS MAKES NO RECOMMENDATION WITH RESPECT
TO PROPOSAL 3.</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">The Company&rsquo;s proposal to ratify the appointment of Ernst &amp; Young LLP as the Company&rsquo;s
independent registered public accounting firm for 2025.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> FOR</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> AGAINST</TD>
    <TD STYLE="vertical-align: bottom; width: 25%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> ABSTAIN</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 12pt">DATED: ____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">____________________________________<BR>
(Signature)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">____________________________________<BR>
(Signature, if held jointly)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">____________________________________<BR>
(Title)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">WHEN SHARES ARE HELD JOINTLY, JOINT OWNERS
SHOULD EACH SIGN. EXECUTORS, ADMINISTRATORS, TRUSTEES, ETC., SHOULD INDICATE THE CAPACITY IN WHICH THEY ARE SIGNING. PLEASE SIGN EXACTLY
AS NAME APPEARS ON THIS PROXY.</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  V ,X# 2(  A$! Q$!_\0
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M_P"OI?Y&OG^N@^7)OM=Q_P _$O\ WV:/M=Q_S\2_]]FH:* )OM=Q_P _$O\
MWV:/M=Q_S\2_]]FH:* )OM=Q_P _$O\ WV:/M=Q_S\2_]]FH:* )OM=Q_P _
M$O\ WV:/M=Q_S\2_]]FH:* )OM=Q_P ]Y?\ OLT?:[C_ )^)?^^S4-% $WVN
MXQ_Q\2_]]FOJGP7E_!FD%B23:H22>3Q7RCVKZM\%'_BBM'_Z]4_E0!O4444
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MG_[_ !HHH /^%-^$O^?2?_O\:/\ A3?A+_GTG_[_ !HHH 0_!SPD!_QZ3_\
8?XUU]A80Z98065J"L,"!$!.< 444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  V ,X# 2(  A$! Q$!_\0
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M -]FC[7<?\_$O_?9J&B@";[7<?\ /Q+_ -]FC[7<?\_$O_?9J&B@";[7<?\
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AA(#_ (])_P#O\:Z^PL(=,L(+*U!6&! B G. *** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  V ,X# 2(  A$! Q$!_\0
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MJCXIT%?$OAV\TN60IYZ_*_\ =8<C]:VJ* /)=%\+?$31]/71+:_L+?3@Q47
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MPIOPE_SZ3?\ ?XT?\*;\)?\ /I-_W^-%% !_PIOPE_SZ3?\ ?XT?\*;\)?\
M/I-_W^-%% !_PIOPE_SZ3?\ ?XT?\*;\)?\ /I-_W^-%% "'X.>$@/\ CTG_
: ._QKL+"PATRP@LK4%88$"("<X HHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
